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ABSTRACT 
Synechocystis sp. PCC 6803 is a readily transformable cyanobacteria used to study 
cyanobacterial genetics, as well as production of biofuels, polyesters, and other industrial 
chemicals. Free fatty acids are precursors to biofuels which are used by Synechocystis 
cells as a means of energy storage. By genetically modifying the cyanobacteria to expel 
these chemicals, costs associated with retrieving the products will be reduced; 
concurrently, the bacteria will be able to produce the products at a higher concentration. 
This is achieved by adding genes encoding components of the Escherichia coli AcrAB-
TolC efflux system, part of the resistance-nodulation-division (RND) transporter family, 
to Synechocystis sp. PCC 6803. AcrAB-TolC is a relatively promiscuous multidrug efflux 
pump that is noted for expelling a wide range of substrates including dyes, organic 
solvents, antibiotics, and free fatty acids. Adding components of the AcrAB-TolC 
multidrug efflux pump to a previously created high free fatty acid producing strain, 
SD277, allowed cells to move more free fatty acids to the extracellular environment than 
did the parent strain. Some of these modifications also improved tolerance to antibiotics 
and a dye, rhodamine 6G. To confirm the function of this exogenous efflux pump, the 
genes encoding components of the AcrAB-TolC efflux pump were also added to 
Synechocystis sp. PCC 6803 and shown to grow on a greater concentration of various 
antibiotics and rhodamine 6G. Various endogenous efflux systems have been elucidated, 
but their usefulness in expelling products currently generated in Synechocystis is limited. 
Most of the elucidated pumps in the cyanobacteria are part of the ATP-binding cassette 
superfamily. The knowledge of the resistance-nodulation-division (RND) family 
transporters is limited. Two genes in Synechocystis sp. PCC 6803, slr2131 and sll0180 
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encoding homologs to the genes that encode acrB and acrA, respectively, were removed 
and the modifications resulted in changes in resistance to various antibiotics and a dye 
and also had an impact on free fatty acid secretion. Both of these deletions were 
complemented independently with the homologous E. coli gene and the resulting 
cyanobacteria strains had some of the inherent resistance restored to chloramphenicol and 
free fatty acid secretion was modified when compared to the wild-type and a high free 
fatty acid producing strain.  
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CHAPTER 1 
INTRODUCTION 
1.1 Impetus and Technological Context 
 Cyanobacteria established our oxygenated atmosphere approximately 2.68 billion 
years ago, based on shales observed in Pilbara Craton, Australia, which are the only two 
preserved Archean crusts (1). The percent of oxygen in the atmosphere increased in a 
step-wise fashion; although, there is some disagreement as to what caused each step Each 
step may correspond to major collision of Earth’s landmasses. Every continental collision 
created supermountains that were unstable and prone to eroding from wind and water. 
This erosion led to vast releases of large quantities of iron and phosphorus into the ocean 
in a relatively small amount of time (2). These element depositions into the ocean created 
similar algal and cyanobacteria blooms to those that are currently observed in the Gulf of 
Mexico and other regions throughout the world. Alternatively, other scientists have 
suggested that the steps were a result of changes in the temperature of the atmosphere, 
more specifically glaciation events where oxygenic cyanobacteria destroyed the methane 
greenhouse (3). Irrespective of the process of oxygenation, the resulting oxygenated 
atmosphere allowed for the evolution of a far more energy-intensive organism, dependent 
on aerobic respiration, which is about 18 times more efficient than anaerobic respiration 
(4). Through the millennia, large carbon sinks increased, buried in the sediments and 
swamps of earth as aerobically respiring organisms died. Coal, the fuel that drove much 
of the industrial revolution and continues to drive many factories and power plants 
around the world, originated predominantly from plants, algae, and fungi (5). But 
petroleum, which has a much greater distribution around the world is derived from algae, 
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cyanobacteria, and ocean plants predominantly as was shown in a 1937 comparison of the 
composition of the various hydrocarbons in existence in petroleum reserves and the 
temperatures at which they can form (6).  
 These consumed fossil fuels that are used with little regard to the consequences, are 
derived from the same organisms that continue to oxygenate the atmosphere while 
simultaneously counteracting the effects of increased greenhouse gas emissions. The 
latest World Meteorological Organization Greenhouse Gas Bulletin explained that 2016 
was the warmest year on record at 1.1oC average air temperature above pre-industrial 
levels (0.06oC above 2015), due, in part, to an increased atmospheric CO2 concentration 
(400ppm in 2015 to 403.3 in 2016) (7). This increasing greenhouse gas pollution stems 
from fossil fuel use; it is also a result of land-use changes from forest to industrial farms 
for livestock and crops, some of which are used to make cellulosic-based ethanol for fuel 
(8, 9). Currently, traditional land plants (corn, sawgrass, e.g.) are used to produce ethanol, 
which can be utilized as an additive to gasoline theoretically in order to reduce 
greenhouse gas emissions (10). However, as the practice became widespread in the early-
2000s, researchers started investigating if this process actually does reduce greenhouse 
gas emissions when the energy required to transform an ear of corn into ethanol is 
considered (11). One study found that 29% more energy was consumed to make a gallon 
of ethanol than it was proposed to have saved, when production of corn, transportation, 
and fermentation/distillation processes were calculated (12). This neglects the negative 
impact of soil erosion, pesticide use, and algal (and cyanobacterial) blooms caused by 
agricultural runoff.  
 Not only is corn a wasteful way to make ethanol, the plant itself is inefficient at 
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using photosynthesis to convert the Sun’s energy to make sugars. Photosynthetic bacteria 
are approximately ten times more efficient than land plants at capturing the sun’s energy 
and converting it into usable energy, at a rate of approximately 10% (13). Synechocystis 
sp. PCC 6803 is a single-celled photosynthetic bacterium that is being investigated for its 
usefulness in production and exportation of biofuels, polyesters, and other chemicals 
from minimal media sources using light, water, and atmospheric carbon dioxide (14–18). 
All of these chemicals reach concentration at which they are toxic to the cell, inhibiting 
production, and yet there remain limited studies as to the cellular effects of the each of 
these. One method to alleviate this toxicity is to increase export rates prior to internal 
accumulation. In addition, a secreted product is far easier to retrieve than one stuck 
within the cytoplasm. However there remains little understanding of the many putative 
proteins responsible for efflux of endogenously produced molecules that are destined for 
the cell surface or are waste products in cyanobacteria when compared to our knowledge 
of Escherichia coli or Saccharomyces cerevisiae. Nor is there much understanding of 
transportation processes of those chemicals produced by the genetically modified 
versions of the cyanobacteria. This understanding of chemical transport can have a 
critical role promoting the efficiency of converting CO2, water, sunlight, and minerals 
into producing and purifying industrially relevant chemicals from cyanobacteria.  
 
1.2 Dissertation goals and outline  
 There is a common theme throughout the chapter to identify phenotypes conferred 
by varying native and exogenous genes that encode resistance-nodulation-family (RND) 
transport proteins. The cell wall, with its many transport proteins and porins, is a critical 
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feature for transporting chemicals in and out of the cell, yet Synechocystis sp. PCC 6803 
possesses a variety of little-explored mechanisms that this research aims to elucidate 
throughout the following chapters. To identify the native mechanisms of Synechocystis 
sp. PCC 6803, SD100, a single-colony isolate of Synechocystis sp. PCC 6803 will be 
used. 
 I begin the research investigating two putative proteins that have been identified in 
the plasma membrane of SD100 (19, 20); I want to see if SD100 genes slr2131 and 
sll0180 encode proteins that are homologous to E. coli proteins AcrA and AcrB. The 
Escherichia coli proteins AcrA and AcrB, in conjunction with outer membrane duct 
TolC, are responsible for the efflux of a wide variety of molecules including antibiotics, 
detergents, free fatty acids (FFAs), and dyes including the namesake of the proteins, 
acriflavine (21, 22). There has been limited research on the efflux in cyanobacteria of the 
resistance-nodulation-division (which includes AcrB) family transporters responsible for 
efflux. Only one study that does more than identify the location of the Synechocystis 
efflux proteins in the membrane by showing that the loss of function of the AcrB 
homolog hampers efflux of various chemicals (23). I accomplish my goals by creating a 
suicide vector for each of the genes that I would like to remove, generating four strains 
based on either SD100 or a previously created high FFA producing variant of SD100, 
SD277, that have either slr2131 or sll0180 exchanged for aphA, a gene that confers 
resistance to kanamycin (Kan), through the process of allelic replacement. The sll0180 
and slr2131 mutant strains of SD277 possesses significant decreases in the extracellular 
FFA concentrations and increased intracellular FFA concentrations. Both sll0180 mutant 
strains possess lower tolerance to each of the antibiotics and R6G. The slr2131 
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strains are more of a mélange, with varied tolerances to antibiotics and R6G compared to 
their respective parent strains. 
 There were a number of strategies applied in this research to accomplish the 
overarching goals, which is to improve fatty acid accumulation outside of the 
cyanobacteria cells so that these hydrocarbons can be used in the production of biofuels, 
while also filling some knowledge gaps with respect to cyanobacterial efflux. Purification 
of FFAs from inside of the cell is more difficult than that if they are present supernatant; 
modification of the efflux systems in cyanobacteria could eliminate the necessity for 
lysing and drying of the cells. This would allow the cells to continue to grow and produce 
while simply removing FFAs from the growth media. To accomplish this goal, I added 
genes that encode components of the E. coli multidrug efflux pump, AcrAB-TolC by 
creating a series of expression vectors that were then added to SD100 and a high fatty 
acid producing strain, SD277. All 10 of these subsequent strains were tested for 
intracellular and extracellular FFA concentrations. Then, in addition to FFA secretion, I 
wanted to show that the protein(s) that make up this pump are indeed affecting secretion, 
so I exposed the cells to a number of antibiotics and the dye, rhodamine 6G (R6G). The 
added genes again benefitted the cells, but this time both for the SD100 and the SD277-
based strains. There is minimal research on synthesizing exogenous membrane transport 
proteins in cyanobacteria, so this study helps to elucidate the potential wide-ranging uses 
for such a system.  
 In the penultimate chapter, the four strains that contained a deletion mutant of 
slr2131 or sll0180 were complemented with the E. coli gene homologous to it, acrB or 
acrA, respectively. I was particularly interested to see what effects a complementation 
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experiment would have on the deletion mutants as the mutants had varying phenotypes 
throughout the first set of experiments, but the mutation predominantly caused decreased 
tolerance to antibiotics and R6G. Only the tolerance to Cm was restored in the 
complementation strains, but SD277 with the deletion of slr2131 and the 
complementation using the E. coli acrB gene had the highest extracellular of FFAs of any 
strain tested in these experiments, providing evidence that AcrB can move FFAs out of 
the SD277 cell. The addition of E. coli acrA, did not increase extracellular FFA 
concentrations of the sll0180 deletion strains significantly, indicating that E. coli acrA 
may not have the adaptor protein in SD100. 
 My final section concludes the findings of the research and applies the context that 
the findings of this research can be used in both adding to the tools of using 
cyanobacteria to produce industrially-relevant chemicals and furthering the understanding 
of efflux in SD100. I also present the context for biofuel research in the current state of 
energy technologies. 
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CHAPTER 2 
BACKGROUND: UNDERSTANDING EFFLUX OF SYNECHOCYSTIS SP. PCC 6803, 
ITS HOMOLOGOUS SYSTEMS, AND THE INDUSTRIAL CONTEXT 
2.1 Synechocystis sp. PCC 6803 as a cell factory 
 Synechocystis sp. PCC 6803 is a single-celled cyanobacterium with a 3.6Mb 
genome that is relatively easy to manipulate when compared to eukaryotic algae (24–26). 
With a cell generation time between 6 and 48 hours, the growth is slower than most 
conventional bacteria used for genetic studies and production of industrially relevant 
chemicals (27). For example, E. coli is commonly used for bacterial research and 
chemical production; its generation time is 15-20 min (28). Additionally, unlike the 
single genome copy of E. coli, Synechocystis sp. PCC 6803 has between 10-14 copies of 
its genome (29, 30). Foreign genes must be placed in each copy of the cyanobacterial 
genome for the alteration to be stable through generations, adding more time for new 
strain production. While initial generation of cyanobacterial modification are more time-
consuming and difficult to achieve than E. coli, the cyanobacteria do not require sugars to 
grow. They instead rely on sunlight, CO2, water, and basic minerals at low 
concentrations, making cyanobacteria less expensive to grow when compared to 
heterotrophic organisms. Additionally, these cyanobacteria grow much faster and at 
higher concentrations of CO2 (when submerged in water) than land crops (26). 
Cyanobacteria are more ideal to use than land crops since they do not require arable land. 
Idyllically, using cyanobacteria to consume atmospheric CO2 and using that sequestered 
atmospheric CO2 for human energy needs, we can stop removing sequestered carbon 
from subterranean environments that has led to ever-increasing greenhouse gas 
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emissions. However, the more energy used to purify the FFAs from cyanobacteria for 
fuel creation, the further from carbon neutral this process becomes. When producing 
FFAs with cyanobacteria, 70-80% of the cost deals with harvesting the cells, lysing, 
drying the products, and extracting the lipids with solvents (14, 31). This can be reduced 
if some of these steps are removed, namely cell harvest and lysis. In turn, this step 
reduction saves both energy costs for production and environmental costs by pushing the 
process towards carbon neutral. Simply secreting the products and collecting the products 
from the supernatant can achieve this goal.  
 While emphasis has been given here to FFA production, cyanobacteria have also 
been engineered to create a number of other biofuels including hydrogen, ethanol, 
butanol, isoprene hydrocarbons, isobutanol, and fatty alcohols (18, 32–38). Hydrogen 
production in Lyngbya aestuarii BL J, a marine cyanobacteria that resides in mats, was 
shown to be 45-times greater than Synechocystis sp. PCC 6803 at producing hydrogen 
during a fermentation assay in which the strains were grown in aerobic, illuminated 
conditions during the day and dark, anoxic conditions at night (32). The L. aestuarii BL J 
did not require any genetic modifications, while the Synechocystis cyanobacteria did 
require the removal of the type I NADPH-dehydrogenase complex for this maximal, yet 
inferior hydrogen production. L. aestuarii BL J resides in microbial mats in which 
conditions at night quickly become anoxic in the cell-dense growth conditions, creating 
conditions that facilitate the production of hydrogen though fermentation (33). The 
following cyanobacteria made for biofuel production were formed using Synechocystis 
sp. PCC 6803 as the parent strain. Ethanol was created by disrupting the poly-b-
hydroxybutyrate pathway and inserting alcohol dehydrogenase genes from Zymomonas 
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mobilis, Anabaena sp. PCC 7120, and Synechococcus sp. PCC 7942 (34). Isoprene 
hydrocarbons were created by expression of a codon-optimized isoprene synthase from 
Peuraria montana (35). Isobutanol was produced by adding two Lactococcus lactis 
genes, kivD and adhA, which convert 2-keto acids in alcohols (37). Similar to the creation 
of ethanol, fatty alcohols production necessitates the disruption of the native 
glycogen/poly-b-hydroxybutyrate. Copies of the fatty acyl-CoA reductase gene were 
inserted in its place (38). The strain named SD277 was created to overproduce FFAs by 
deleting native genes and adding foreign genes. The strain successfully increased 
production of 12-, 14-, 16-, and 18-carbon saturated fatty acids (14). A further analysis of 
the strain is included in Chapter 3 due to its pertinence to this research. 
 Utilization of cyanobacteria for chemical production is not specific to biofuels, as 
they are currently used for several other products. Synechocystis sp. PCC 6803 has been 
engineered to create 3-hydroxybutyrate (3HB), a precursor to plastics (16). A precursor to 
synthetic rubbers and polymers, ethylene, was produced in a modified Synechocystis sp. 
PCC 6803 using the expression of the efe gene from Pseudomonas syringae (39). L-
lactate was also produced in Synechocystis sp. PCC 6803 using the Bacillus subtilis ldh 
gene (40). 
 Numerous strains have been created, many of them in using Synechocystis sp. PCC 
6803 as the parent strain, in order to produce products beneficial to society. They include 
modifying native genes and introducing exogenous ones. But nearly all removal of genes 
attempts to affect competing pathways to the pathways that lead to the production of a 
desired chemical, removal feedback inhibition signals, or the weakening of cell wall 
components. The genes added encode proteins responsible for producing the product or a 
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precursor to it. The source of the exogenous genes ranges from other cyanobacterial 
species to eukaryotic plants. There has been limited research identifying exogenous genes 
that are added that yield proteins responsible for active efflux of industrially relevant 
chemicals. 
 
2.2 Limited understanding of efflux in Synechocystis sp. PCC 6803 
 Efflux is a critical consideration when using these cyanobacteria as a production 
factory. Many of the chemicals that can be produced become toxic when researchers 
begin removing feedback inhibition loops and adding exogenous genes or upregulating 
native ones. In fact, the chemicals themselves that are the limiting factors. The production 
of ethanol in cyanobacteria may be limited by the ethanol produced because of their 
inherent lack of tolerance to it (41). Numerous research groups have been actively 
producing ethanol in Synechococcus sp. PCC 7942. Researchers have overexpressed an 
endogenous alcohol dehydrogenase gene, adhA, and added an exogenous alcohol 
dehydrogenase pyruvate decarboxylase from Zymomonas mobilis (34, 42). These genetic 
modifications led to significant increases in ethanol production but raised concerns 
regarding the cells’ tolerance to the chemicals produced in far higher concentration than 
in a wild-type cell. By removing a number of genes encoding putative transport proteins, 
one group discovered a function of Slr0982, an ATP-binding cassette (ABC) efflux 
transporter, which moves ethanol out of the cell (43). With this knowledge of how the 
bacterium’s native mechanism operates, more genetic modifications can be performed to 
accompany the increased ethanol production in the cell. These include modifying the 
promoter sequence of slr0982, optimizing the codons that encode the protein of Slr0982, 
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or adding exogenous genes shown to move ethanol out of a bacterial cell. One example is 
the FPS1 gene found in Saccharomyces cerevisiae that has been shown to limit ethanol 
concentrations in the yeast cell through ethanol efflux (44).  
 There are far fewer proteins in Synechocystis destined for active membrane 
transport than in E. coli, which possesses 79 ABC family proteins, making up 69 
independent systems as some function in multiple structures. Of the 69 proteins, 57 are 
transporters; there is a limited understanding of the remaining proteins. What is of 
particular note is that of the 57, 44 are uptake systems while only 13 are efflux systems 
(45). There are 11 identified ABC transporters in Synechocystis sp. PCC 6803. The 
identified exporters include Evr, Slt, Slr0982, Sll1180, and Slr2019, while the following 
are ABC importers: Bgt, Urt, Fut, Ggt, Nat, and Mnt (23, 43, 46–52). Instead of having a 
3:1 ratio of importers to exporters as in E. coli, Synechocystis sp. PCC 6803 possesses 
close to a 1:1 ratio, likely reflecting the necessity for E. coli to move more chemicals into 
their cells, namely sugars for energy. Synechocystis does not require uptake of any sugar, 
but instead small chemicals such as iron (through the Fut transporter), necessary for 
photosynthesis that yields the sugar a cyanobacterium requires for survival. The ABC 
exporters of Synechocystis sp. PCC 6803 are responsible for efflux of viologen 
herbicides, phosphatidylglycerol, O-antigen, and lipid A (50, 53).  
  No small multidrug resistance (SMR) family proteins have been predicted nor 
observed in Synechocystis sp. PCC 6803 (54). Two multi antimicrobial extrusion 
(MATE) proteins have been predicted and the deletion mutants of slr0896 and slr1543, 
each produced strains that exhibited increased sensitivity to acriflavine and methyl 
viologen (53). There exists a total of six open reading frames that have been identified as 
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the major facilitator superfamily (MFS) transporters. But, only two of the putative MFS 
proteins, which includes Sll1154 and Slr0616, have been found to exist in the membrane; 
each is induced by cold-weather, but no functions have been identified (55–57). 
Researchers were investigating mechanisms of cold resistance in cyanobacteria for an 
understanding of cold-response in photosynthetic organisms (57). Another efflux system 
for bacteria is the resistance-nodulation-division (RND) family. There are five pumps 
belonging to this family that have been predicted in Synechocystis sp. PCC 6803, 
including the Slr2131. Further explanation of the RND pumps and their associated 
membrane fusion proteins is contained in Chapter 3, but Slr1270 is a Synechocystis sp. 
PCC 6803 membrane channel that is predicted to operate in conjunction with ABC and 
RND efflux systems to extrude chemicals out of the cell in a similar manner to the 
function of TolC in E. coli—outer membrane duct that allows for passive flow of 
chemicals out of the cell (58). 
 The possible role of slr1270 in Synechocystis sp. PCC 6803 was first mentioned in 
the literature in 2004 (59), but the description of the actual function was not published for 
a decade. Initially, the Slr1270 protein was determined to be a homolog to the E. coli 
TolC protein by isolating the outer membrane of Synechocystis via sucrose density 
centrifugation and aqueous two-phase partitioning that was then mapped out on 2D-
PAGE (60). This proof that Slr1270 is present in the outer membrane of Synechocystis, 
led investigators to then compare the gene sequence to that of TolC and 10/11 peptides 
matched (59). The gene slr1270, was then expressed in E. coli in which its structure, size, 
and function were observed. When studying the conductance of the channel when 
exposed to KCl, the results actually suggested a larger pore than that of E. coli TolC. But, 
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Slr1270 likely has a similar function based on ion-sensitivity, displaying a potential 
voltage similar to TolC when exposed to a potassium gradient. The structure is also 
similar based on the sequence of amino acid residues (60). 
 In 2015, researchers in Portugal continued this research by investigating the role of 
Slr1270 in respect to protein and metabolite efflux in vivo in Synechocystis sp. PCC 6803 
(61). This research group removed part of the slr1270 gene from the Synechocystis sp. 
PCC 6803 genome using a substitution deletion, performing a homologous recombination 
with a gene cassette conferring resistance to Kan and observed a number of phenotypic 
alterations. First, the researchers modified the growth conditions, finding that the slr1270 
mutant is more susceptible to colder temperatures and a number of antibiotics. The flasks 
in which the mutant cells were grown had less accumulation of cyanobacterial cells on 
the sides of the Erlenmeyer flask in which the bubbles, due to the aeration, were popping, 
compared to Synechocystis sp. PCC 6803. The authors indicated that this lower number 
of cyanobacterial cells affixed to the Erlenmeyer flask indicated a lower amount of 
biofilm formation. The modified cells also secreted fewer proteins. The following 
proteins were not present in the extracellular space of the slr1270 mutant strain but were 
present in the extracellular space of Synechocystis sp. PCC 6803: Sll0723, Sll1951, 
Sll1009, and Slr1751. Based on transmission electron microscopy (TEM), the mutants 
lacking slr1270 may be lacking the key structures of the S-layer, likely secreted through 
the outer membrane duct, Slr1270. This research hypothesizes that there are efflux pumps 
in Synechocystis sp. PCC 6803 that use this channel to secrete various chemicals, yet 
none have been shown to do so.  
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2.3 The role of multidrug efflux transporters in Escherichia coli 
 E. coli has been a model organism for the better part of its recorded history since its 
isolation from the human colon (62). It became notable beginning in the 1960s for its 
ability to survive with a number of dyes and detergents (22, 63) and then later with 
antibiotics, in which hospital patients were shown to serve as hosts for antibiotic-resistant 
E. coli (64–66). In the early 2000s, research began showing the structures of some of 
these pumps, promoting the expansion of this research field, which allows a better 
understanding of these patients’ bacteria and for exploration into other uses for these 
pumps (67, 68).  
 There are five main types of efflux pathways in bacteria: The ABC transporter 
family that relies on ATP from ATP hydrolysis for substrate relocation. The other four, 
include RND, MFS, SMR, and MATE, which rely on a proton gradient across the 
membrane (69).  
 The ABC family is a well-studied efflux transporter system found in nearly all 
branches of life, including humans in which an ABC transporter is located in the blood-
brain barrier, often hampering the effects of therapeutics destined for the brain by 
extruding them (70). E. coli possesses examples of each of these efflux pump systems 
that have a specific function in the cell. E. coli uses the BtuCD-F system for Vitamin B12 
uptake (71), while the MsbA ABC transporter moves lipid molecules from the cytoplasm 
across the inner membrane (72). EmrD, part of the MFS family, is responsible for the 
efflux of detergents and carbonyl cyanide m-chlorophenylhydrazone, an inhibitor to 
oxidative phosphorylation (73–75). SMR proteins are usually 100-140 amino acids in 
length some of which, such as YdgE and YdgF, confer resistance to drugs like ethidium 
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and methyl viologen (76). MATE pumps are not researched often in E. coli other than to 
use an E. coli strain that is hypersusceptible to antimicrobials to investigate the MATE 
pumps from other bacteria such as the Staphylococcus aureus MepA pump (77). While 
this is not a complete list of transporters in E. coli, these reflect some of the more 
completely studied examples. 
 The final efflux system, and the one used as a catapult for this research, is the RND 
system. It uses one outer membrane duct, the membrane-fusion protein (MFP), and the 
RND efflux pump in the periplasmic membrane (69). With the combination of these three 
proteins, the cell can launch various substrates through the inner and outer membranes 
and the periplasm. One common outer membrane duct is TolC of E. coli that associates 
with the MFP, AcrA, and the efflux pump, AcrB (78). For reference please review Figure 
2.1. Without any one of these three components, E. coli cells become hyper susceptible to 
a range of antimicrobial agents including antibiotics, dyes, organic solvents, and 
detergents (63, 79, 80). This type of efflux pump is not uncommon. Neisseria 
meningitidis and N. gonorrhoeae have the farAB efflux pump responsible for fatty acid 
resistance as the bacteria colonize the human nasopharynx (81). Pseudomonas 
aeruginosa uses RND pumps to acquire widespread resistance to antibiotics throughout 
hospitals through hyperexpression of the genes that encode the MexAB-OprM efflux 
pump, a homolog to the E. coli AcrAB-TolC system (82, 83). This research looks to 
further the understanding of RND transporter in Synechocystis sp. PCC 6803 and SD277 
in addition to using exogenous E. coli transporters in the cyanobacteria. 
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Periplasm
Extracellular environment
Cytoplasm H+ Substrate pathway
AcrB
TolC
AcrA
Fig. 2.1 Schematic of the AcrAB-TolC multidrug efflux system as established in E. coli. 
The blue cylinder represents the TolC exit duct. The green trapezoid with two tails 
represents two AcrA adaptor proteins. The three red rectangles sans corners represent the 
AcrB homotrimer transporter protein. 
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2.4 Exogenous transporters synthesized in cyanobacteria 
 Cyanobacteria have evolved in limited-nutrient conditions, which may be the 
reason they possess two-fold fewer transport systems relative to genome size when 
compared to pathogenic bacteria like Escherichia coli. However, these two groups of 
bacteria have a similar number of drug resistance transporters suggesting both need to 
export toxins from the cells (84). As photoautotrophs, cyanobacteria do not import 
nutrients in the same quantities as heterotrophic bacteria; therefore, they lack many of 
import mechanisms that E. coli and other heterotrophic bacteria possess.  
 As discussed in Chapter 2.1, many exogenous genes, including those from other 
bacteria and eukaryotic plants, have been expressed in Synechocystis and other related 
cyanobacteria for use in chemical production. However, few of these genes additions 
address active efflux and those that do focus entirely on sugar efflux, predominantly in 
Synechococcus elongatus sp. PCC 7942. Genes encoding transporters from E. coli and 
Zymomonas mobilis were expressed in Synechococcus elongatus sp. PCC 7942 (85). The 
GLF protein from Z. mobilis allows for diffusion of glucose and fructose across the 
membrane in or out of the cell without phosphorylation of the sugar. The LldP protein 
from E. coli is classified as a lactate permease protein that facilitates L-lactate transport 
through a proton/substrate exchange across the membrane, but the LldP protein can also 
transport D-lactate and glycolate across the membrane (86, 87). The E. coli gene invA 
encodes the protein InvA that cleaves sucrose to glucose and fructose. Each of the genes 
were placed in Synechococcus elongatus sp. PCC 7942 and the proteins InvA, GLF, and 
LldP were successfully synthesized.  Fructose and glucose were both successfully made 
and secreted from the genetically modified cyanobacterial cells that produced proteins 
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InvA and GLF. This research provides insight into the possibilities of E. coli genes being 
synthesized and having the same function in cyanobacteria that the exogenous proteins 
had with respect to the transport of sugars through cell membranes in their native E. coli 
bacterium cell. 
 Multiple examples exist of introducing exogenous sugar transporters into 
cyanobacteria to promote growth in the dark, which are often unable to simply transport 
the sugar into the cells. This was shown by adding either glucose transport gene glut1 
from human erythrocytes or hup1 from Chlorella kessleri, an algae, to Phaeodactylum 
tricornutumcan that allowed the organism to grow in the dark (88). Another example of 
exogenous transport protein synthesis in cyanobacteria also involved Synechococcus 
elongatus. The cyanobacteria grew continuously in diurnal conditions by adding the 
galP, xylE, xylA, and xylB genes from E. coli (89). Cyanobacteria do not grow when the 
sun sets or the incubator lights are switched off, exhibited by a change in gene expression 
to facilitate respiration and 3-polyhydroxybutryrate (3HB) synthesis that are upregulated 
at the shift from day to night (90).  
 These studies elucidate the basis for using E. coli transport genes in cyanobacteria 
to facilitate chemical movement. In Synechococcus elongatus, both efflux and uptake of 
sugars have been demonstrated in cells that could not perform either before the genetic 
modifications. My research addresses the possibility of using E. coli RND transporters to 
more FFAs out of the cell in cyanobacteria, expanding on the existing body of research 
using exogenous proteins from E. coli in cyanobacteria to transport chemicals while 
furthering the understanding of the native RND mechanisms in Synechocystis sp. PCC 
6803.  
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Chapter 3 
REMOVING PUTATIVE TRANSPORT GENES FROM SYNECHOCYSTIS SP. PCC 
6803 AFFECTS FREE FATTY ACID SECRETION AND TOLERANCE TO 
ANTIBIOTICS AND A DYE 
3.1 Introduction 
3.1.1 Overview and hypotheses 
 The genome of Synechocystis sp. PCC 6803 has been routinely modified for a 
variety of reasons including the understanding of photosynthesis to the production of 
ethanol and FFAs for fuel. The high FFA producing strain, SD277, was created to 
significantly increase the amount of various FFAs produced by a Synechocystis sp. PCC 
6803 cell when compared to its wild-type parent strain, SD100 (14). In this research, I 
hypothesized that the FFAs are actively moved out of the cells. However previous 
research, including the Liu et al., 2011 research article that originally described the 
creation and testing of SD277, hypothesized that FFAs are transported out of the cell 
passively. This passive mechanism is described as the “flip-flop” method in which polar 
intracellular FFAs pass through the lipid bilayer that makes up the membranes (91, 92). 
The FFA from the lipid membrane is then ejected into the extracellular space. I want to 
identify possible active mechanisms for the secretion of FFAs and elucidate if those 
mechanisms are also responsible for tolerance to antibiotics and R6G, a dye shown to be 
secreted in E. coli by the AcrAB-TolC efflux pump.  
 I hypothesize that removal of the gene that encodes the putative efflux pump, 
slr2131, adversely affects secretion of FFAs and tolerance to antibiotics and R6G. In 
addition, there are a couple of proteins whose genetic code bear homology to the MFPs of 
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the RND and ABC efflux systems. In this study, I hypothesize that the removal of the 
gene that encodes one of those putative MFPs, sll1080, will also adversely affect FFA 
secretion and tolerance to antibiotics and R6G. In order to test my hypotheses, I needed 
to remove each of the genes from the cyanobacterial cells in both SD100 and SD277. I 
accomplished this by creating a vector that recombines with the flanking regions beside 
each of the genes of interest, swapping a nucleotide cassette that confers resistance for 
Kan in place of the gene of interest. Once these four strains were created, I then 
performed an assay in which the mutant strains were grown in culture with varied 
concentrations of three antibiotics and R6G to find the half maximal inhibitory 
concentration (IC50). In addition, I grew 100mL cultures of all four strains using aeration 
to promote dense growth that were then used to identify FFAs in the supernatant 
corresponding to extracellular FFA concentration, and, using the Folch Method, I 
extracted the FFAs out of the intracellular space to measure the intracellular FFA 
concentration.  
3.1.2 Proteins responsible for RND efflux in cyanobacteria 
  Based on the nucleotide sequence, there are 7 open reading frames in 
Synechocystis sp. PCC 6803 that may encode RND transporters (54, 93): slr0369, 
slr0454, sll0142, sr0794, slr6042,  slr6043, and slr2131. No research has been performed 
with respect to the proteins encoded by slr0794, slr6042, or slr6043, so their exact 
functions remain unknown. Of proteins encoded by the aforementioned genes that have 
been investigated, Sll0142 was shown to be located in the membrane of Synechocystis sp. 
PCC 6803. Strains with a mutation of slr0369, in which a gene cassette conferring 
resistance to Kan was recombined into the middle of slr0369, possessed altered pilin 
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glycosylation and increased susceptibility to sodium dodecyl sulfate (SDS), likely 
reflecting an efflux mechanism (23). A strain with a mutation of slr0454 was found to be 
more susceptible to chloramphenicol (Cm) and is a suspected alter efflux route for the 
slr2131 gene product (23). I found that slr2131 shared significant homology to E. coli 
acrB, as discussed in the following section, and decided to pursue an investigation of it. 
 The other regularly investigated RND efflux pump has been shown to be used for 
efflux of copper in Synechocystis sp. PCC 6803. The CopRS system modulates copper in 
the cell as it is necessary for many cellular processes, but can become toxic as the 
concentrations increase (94–98).  
3.1.3 Identifying the homologs of AcrA and AcrB 
 Numerous studies have identified the location and existence of the proteins Slr2131 
and Sll0180 in the cell membrane of Synechocystis sp. PCC 6803 (20, 56, 59, 99, 100). I 
examined the genetic homology of each of the genes encoding proteins Slr2131 and 
Sll0180, slr2131 and sll0180 respectively, to potential homologous genes in E. coli. The 
Synechocystis sp. PCC 6803 gene, slr2131, has previously been observed to have 
increased expression when Synechocystis sp. PCC 6803 is grown in the presence of 
hexane (101). Hexane is one of the many substrates of AcrB in E. coli (102), so I 
compared the nucleotide sequence of slr2131 to acrB, the E. coli gene encoding the AcrB 
multidrug efflux pump. The acrB gene is located in an operon with acrA in the 
chromosome of E. coli so I then compared sll0180 to acrA, the E. coli gene encoding the 
AcrA MFP.   
 The Slr2131 protein is a homolog to AcrB/AcrD/AcrF family of multidrug efflux 
pumps (20). Slr2131 is found exclusively in the plasma membrane of Synechocystis sp. 
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PCC 6803 (19). The function of the E. coli protein AcrB is understood as the actual pump 
that expels antibiotics from bacterial cells with the assistance of the adaptor, AcrA, and 
exit duct, TolC (66). The relationship and interaction between AcrA, AcrB, and TolC is 
intensively reviewed in Chapter 4, in which I describe the addition of these genes to the 
various Synechocystis strains. Current research findings based on the genetic sequence 
analysis and location of each protein provide some insight as to the function of 
Synechocystis sp. PCC 6803 proteins Slr2131 and Sll0180, but my research looks to find 
phenotypic differences in strains lacking the native genes that encode these two proteins. 
The Synechocystis sp. PCC 6803 gene, sll0180, is the least studied of the three deleted 
genes in this work. Only a genetic analysis and protein localization of Sll0180 has been 
completed, in which is it hypothesized that Sll0180 is one of four predicted MFPs 
responsible for anchoring Slr1270 to the cell membrane (59). Slr1270, as highlighted in 
the previous chapter, is a homolog to E. coli TolC, the outer membrane duct that allows 
passage of the substrates of the AcrB pump through the outer membrane. Sll0180 is one 
of two predicted MFPs that is a lipoprotein, with the other being Sll1053 (20, 99). AcrA 
is also a lipoprotein, anchored to the inner membrane using a lipid moiety further 
pointing to the conclusion that AcrA and Sll0180 have the same function in their 
respective organisms. 
 The nucleotide sequence homology between slr2131 and acrB is a 55% identity 
with 10% of the Needleman-Wunsch alignment requiring gaps to facilitate maximal 
homology (103). The two genes only vary by 36 nucleotides in length, in which acrB 
consists of 3150 and slr2131 has 3186. This is strikingly similar when one considers that 
Escherichia and Synechocystis genera diverged evolutionarily somewhere between 3.1 
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and 3.254 billion years ago (104–107), an especially long time ago considering the oldest 
known cyanobacteria fossils are 3.5 billion years old (1). This divergence can be 
compared to that of Escherichia coli and closely related Salmonella enterica, diverged 49 
to 166 million years ago (107–109). The closest matching gene to the E. coli acrB in 
Salmonella enterica is also called acrB and shares almost complete homology with an 
identical length of 2150 nucleotides in which 86% of the nucleotides matched with 
virtually no gaps required for this alignment.  
 There were two genes considered for removal to identify a potential RND MFP, 
sll1053 and sll0180. At the time of deciding, there was no research identifying the 
function of either, so I made the determination based on a BLAST search of similar 
sequences in the SD100 chromosome to E. coli acrA in which I quickly narrowed down 
the search to sll1053 and sll0180. Both were about 25% longer than the 1194 nucleotide 
sequence of E. coli acrA, and the aligned sequences had evenly spaced gaps. The 
sequence identity of sll1053 and acrA is 46% with 28% of the alignment requiring gaps 
to facilitate the homology. The other potential homolog of E. coli acrA is SD100 sll0180, 
which had a sequence homology that was also 46% when compared to E. coli acrA but 
had slightly fewer gaps required to align the sequences at 25%. So, then I was curious 
exactly how conserved are the sequences of these two cyanobacterial genes. When 
sll1053 is compared directly to sll0180, there is only a 51% identity with 18% of the 
nucleotides representing gaps. If you compare the sequences of acrA to another E. coli 
membrane fusion protein responsible for an RND efflux pump, acrE, they are far more 
homologous with 67% identity and only 5% sequence needing gaps to perfect the 
alignment and a total nucleotide length within 33 base pairs of each other, 1155 bp length 
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of E. coli acrE compared to 1188 of acrA.  
 When comparing the protein sequences of the native Synechocystis sp. PCC 6803 
proteins to the homologs in E. coli, AcrA is created from 397 amino acids while Sll0180 
is composed of 501 amino acids. The first 131 amino acids of Sll0180 share an 18% 
identity to AcrA and, similarly, nearly the last 262 amino acids of Sll0180 share a 19% 
identity to AcrA (Sll0180 amino acids 500 and 501 were not included in this identity 
analysis) (110). But this leaves the gap from amino acids 132 to 237 in Sll0180, bearing 
virtually no homology to AcrA. AcrB share far more protein sequence homology to 
Slr2131 relative to the comparison between AcrA and Sll0180. Slr2131 has a protein 
sequence length of 1061 amino acids, while AcrB has 1049 amino acids. Amino acid 2 
through 1017 of Slr2131 watched matched with the a 1016 amino acid length central 
region of AcrB for a 41% identity with no gaps in the alignment (110), indicating that the 
vast majority of the two proteins sequences share protein binding sites and 
transmembrane domains that a paramount to the functioning of each pump. 
3.1.4 The high fatty acid producing Synechocystis strain 
 SD277 is a strain derived from SD100 (a single colony isolate of Synechocystis sp. 
PCC 6803), previously created with a series of genetic deletions and additions that 
dramatically increase the levels of FFA production (14). In order to survive, SD277 has 
an ability to release FFA. However, a clear mechanism for release has yet to be 
demonstrated, while the authors present the idea of a “flip-flop” method for release, but 
there is no empirical evidence that this is the case in SD277 FFA production. In the first 
series of modifications, the Synechocystis 6803 gene slr1609 was removed and replaced 
with the E. coli gene tesA lacking its signal sequence (‘tesA), to trap the enzyme in the 
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cytosol and prevent it from moving to its normal location in the periplasm. In E. coli, this 
had the effect of increased accumulation of many of the FFA, some by as much as 26 
times (111). Slr1609 is an acyl-acyl carrier protein (ACP) synthetase, while TesA is an 
acyl-ACP thioesterase. Slr1609 takes FFA and creates Acyl-ACP, while TesA takes 
Acyl-ACP and creates FFA, a more desirable outcome for the production of FFA. Some 
of the modifications to create SD277 include the following gene additions that resulted in 
proteins producing the listed saturated free fatty acids: Cc fatB1 (accumulates myristic 
acid), Uc fatB1 (accumulates lauric acid), and Ch fatB2 (accumulates octanoic and 
decanoic acids). Each encode for ACP thioesterases from Cinnamomum camphorum, 
Umbellularia californica and Cuphea hookeriana, respectively. In addition, slr1951 and 
slr1710 were deleted to weaken the cell membrane to promote for FFA release. The 
following genes were also removed from the SD100 chromosome because the proteins 
encoded by each of the genes is responsible for competing with the FFA synthesis 
pathway and therefore were an impediment to creating a high FFA producing SD100 
strain: slr2132, slr1993, slr1994, slr2001, and slr2002. I hypothesize that an active 
mechanism to rid the cell of the FFA will lead to a higher concentration of FFA outside 
of the cell.  
 
3.2 Materials and Methods 
3.2.1 Growth and culture conditions 
A single cyanobacterial colony is picked by a sterilized loop from a BG-11 media 
plate that has been streaked using cells from -80oC frozen stock and used to inoculate a 
BG-11 medium plate, a universal media for growing cyanobacteria (112), and grown with 
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illumination at 30oC in an environmental chamber (SANYO, Osaka, Japan). If the 
selection or maintenance of plasmid-containing cyanobacteria cells or a cyanobacterial 
strain containing a substitution deletion was necessary, the appropriate antibiotic was 
added at concentrations of 50 µg/mL of Kan and 30 µg/mL of streptomycin (Str) and 
spectinomcin (Spec). The cells were then added to a 1-mL modified BG-11 medium 
buffered by 10 mM N-[tris(hydroxymethyl) methyl]-2-aminoethanesulfonic acid (TES) 
NaOH (pH 8.2) in a glass test tube. The tube is incubated with illumination and 
intermittent shaking for 2–4 d. Once these starter cultures reach an optical density at 730 
nanometer wavelength (OD730) of 0.6 as measured by a spectrophotometer (Thermo 
Fisher GENESYS 10S, Waltham, MA), the samples were transferred to a 10 mL BG-11 
medium culture grown in a 250-mL Erlenmeyer flask with aeration at 100 mL⁄ min. This 
protocol uses TES buffer and air aeration to keep the pH around 8 at the beginning 
inoculation stages to minimize the lag phase. Once the culture reaches a mid-log level 
growth phase, the culture of cyanobacterial can be used to test the IC50 to Amp, Cm, Ery, 
and R6G, using a 1:2 dilution to have a starting OD730 of 0.4. If the culture is to be used 
for FFA analysis, 20 mL of BG-11 media without TES is added to the existing 10mL 
culture, as TES negatively affects FFA concentration (14). This now 30 mL culture is 
grown to a concentration of 8-10x108 cells/mL and then subjected to analysis of  
intracellular and extracellular FFA concentrations.  
3.2.2 Construction of vectors for gene deletion 
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Table 3.1 Primers used to delete slr2131 and sll0180 from SD100 and SD277  
Primer Name Sequence Reference 
A 3Z slr 2131 
end F 
GAG AGA GCT CGA CCC CGT TGT GTT AA this 
research 
A 3Z slr 2131 
center R 
GAT TTA TTT TCT TGG ATC CCA TTA CGG CCG ACA TTG TTA CAT ATC T this 
research 
A 3Z sll 0180 
end F 
CCT GGA GCT CTT GAC AAT GAC GAC AAT C this 
research 
A 3Z sll 0180 
center R 
TTT TTA GTT CTG GAT CCC ATT ACG GCC GTA GTT AAT TGA CTC A this 
research 
B 3Z slr 2131 
center F 
TGT AAC AAT GTC GGC CGT AAT AGG ATC CAA GAA AAT AAA TCT GGT CTT ATT this 
research 
B 3Z slr 2131 
end R 
GCG CGT CTA GAT ATC CCA GTT CCA TTC TTT G this 
research 
B 3Z sll 0180 
center F 
TGA GTC AAT TAA CTA CGG CCG TTG GAT CCA GAG AAC TAA AAA GTC TA this 
research 
B 3Z sll 0180 
end R 
CGG GTC TAG ACT GCT GGG CAT TAT C this 
research 
Kan BamHI CAT TAC ACC AAG GAA TTA GGA TCC GTC GAC C this 
research 
EagI SacB ATA TCG GCC GGA ACA TCG ACA AAT ACA TAA GGA AT this 
research 
2131 w/in A CCA CTT CTT TGG TAT TGA TGG CAG  this 
research 
2131 w/in B GGA GCT TGG ATA ATG GTG ATG AAA TAA  this 
research 
    
Table 3.2 List of Plasmids Used to Delete 
Synechocystis genes 
   
Plasmid Name Description Parent Curtiss Collec. Reference 
pGEM-3Z commercially available cloning vector N/A pGEM-3Z  
pPSBA2KS Vector that harbors sacB-KanR cassette N/A pPSBA2KS          (20) 
p⍦694 pGEM-3Z harboring slr2131flanking regions with sacB-
KanR cassette inserted between 
pGEM-3Z p⍦694 this research 
p⍦695 pGEM-3Z harboring sll0180 flanking regions with sacB-
KanR cassette inserted between 
pGEM-3Z p⍦695 this research 
pSpec Expression vector conferring resistance to Str and Spec RSF1010 p⍦568 this research 
pKan Expression vector conferring resistance to Kan RSF1010 p⍦687 this research 
pacrB Expression vector encoding E. coli acrB p⍦568 p⍦691 this research 
pacrA Expression vector encoding E. coli acrA p⍦687 p⍦692 this research 
ptolC Expression vector encoding E. coli tolC p⍦568 p⍦699 this research 
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 To remove a gene from SD100 or SD277, it must be removed from all 10-14 copies 
of the genome (29). This can be accomplished using the cyanobacterium’s natural uptake 
of plasmids, swapping the gene of interest for a cassette that confers resistance to Kan. 
This allows the newly transformed cells to be selected by growth on Kan-containing 
media. To allow this transformation, I created two plasmids: one to delete slr2131 and 
another to delete sll0180. I will use sll0180 removal as the example, but the exact same 
process is performed for creation of the plasmid to remove slr2131, but with regions 
respective to sll0180. Two 700 base pair regions located immediately upstream and 
immediately downstream of sll0180 were amplified using iProofTM High-Fidelity PCR 
Kit (Bio-Rad, Hercules, CA, USA) from Synechocystis sp. PCC 6803 using 
oligonucleotide primers that I designed (Table 3.1). The “A 3Z sll 0180 end F” and “A 
3Z sll 0180 center R” primers amplified the upstream regions of sll0180, while the “B 3Z 
sll 0180 end R” and “B sll 0180 center F” primers amplified the downstream region. The 
primers (IDT, Coralville, IA, USA) contain a DNA sequence that places distinct 
restriction enzyme cleavage sites flanking sll0180. One restriction enzyme cleavage site 
was placed at the ends of the flanking regions furthest from sll0180, NotI (upstream) and 
SphI (downstream). Two restriction enzyme cleavage sites were placed in the end of each 
flanking region nearest to sll0180, BamHI and EagI, which is the same for each flanking 
region. The first reason for placing the same two restriction enzyme cleavage sites at the 
end of the flanking region closest to sll0180 was to allow the two independently 
amplified flanking regions to be digested by the same restriction enzyme so that the 
flanking regions from either the upstream or downstream ends of sll0180 can be ligated 
together. Once each flanking region was amplified using a colony PCR of SD100, then 
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each DNA fragment is digested with restriction enzyme BamHI. Using the same BamHI 
site for each of the flanking regions allows the two fragments of DNA to be ligated 
together. Then a newly created 1.4kb DNA sequence, containing the upstream region 
attached directly to the downstream region in their native origin, now lacks sll0180 in the 
middle. This was then digested again at either end of the 1.4kb sequence using restriction 
enzymes NotI and SphI to allow the 1.4kb fragment to be ligated into the multiple 
cloning region of high copy number vector pGEM-3Z (Promega, Madison, WI, USA) 
that was also digested with NotI and SphI restriction enzymes using 1 µL the DNA ligase 
enzyme and 1 µL of DNA ligase buffer in a 10 µL reaction volume (NEB, Ipswich, MA). 
The vector was then electroporated into E. coli Top10 cells (Life Technologies, Carlsbad, 
CA, USA) and then the cells were plated on LB with ampicillin (Amp) at a concentration 
of 50 µg/mL and grown overnight at 37oC in lysogeny broth (LB) using the Miller 
modification (113) and supplemented with 1g/L of glucose (all remaining reference to LB 
media hereafter are using the Miller recipe with added glucose). Individual colonies were 
analyzed for the presence of the 1.4kb region of ligated flanking regions using a colony 
polymerase chain reaction (PCR) with the GoTaq reaction mixture (Promega, Madison, 
WI) and the outermost “end” primers, in this case: A 3Z sll 0180 end F and B 3Z sll 0180 
end R (Table 3.1). The thermocycler temperature and time condition were as follows: 
Initial denaturation for 2 min at 95oC, then the next 3 conditions were repeated 30 times 
of denaturation for 1 min at 95oC, annealing for 1 min at 56oC, and extension for 1.5 min 
at 72oC, and finally, the final extension step occurs for 7 min at 72oC. Those primers 
amplified the 1.4kb sequence in pGEM-3Z, if it existed, but did not amplify any sequence 
in the E. coli Top10 genome. Now the reason for having two restriction enzymes 
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cleavage sites between the now ligated flanking regions from the upstream and 
downstream regions of sll0180 and is to force the direction that the sacB-KanR cassette 
was placed between the flanking regions. One end of the sacB-KanR cassette has the NdeI 
cleavage site, while the other end has the KpnI cleavage site based on the primers used to 
amplify the cassette: Kan BamHI and EagI SacB (Table 3.1). The sacB-KanR gene 
cassette was amplified from pPSBA2KS, obtained from the Vermaas group (114), 
plasmid DNA. The two cleavage sites, BamHI and EagI, were digested using 
corresponding restriction enzymes concurrently in both pGEM-3Z bearing ligated 
flanking regions of sll0180. Then the ligation of the sacB-KanR cassette between the 
upstream and downstream fragments of sll0180 occurred using the T4 DNA ligase 
enzyme (NEB). This vector was electroporated into E. coli Top10 cells (Life 
Technologies) and colonies containing this Kan-resistance conferring plasmid was 
identified using colony PCR amplification of the E. coli colonies using the GoTaq 
reaction mixture and the same primers used when identifying the presence of the 1.4kb 
flanking region in pGEM-3Z; however, in this instance the region is now 4.6kb with the 
addition of the of the 1.4kb flanking region to the 3.2kb sacB-KanR cassette so the 
annealing time increases from 1.5 min to 4.5 min. Once identified, the colony containing 
the now identified p⍦695 plasmid was grown overnight in liquid LB media at 37oC. The 
following morning, the replicated plasmid is isolated from the E. coli cells using a 
Miniprep Plasmid Purification Kit (Qiagen, Hilden, Germany). The plasmids are 
summarized in Table 3.2 and stored at -20oC until they are needed. The identical process 
was completed to create p⍦694 with the exception of using the flanking regions of 
slr2131 and corresponding 4 primers (A 3Z slr 2131 end F,  A 3Z slr 2131 center R, B 3Z 
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slr 2131 end R, and B slr 2131 center F) instead of the sll0180 flanking regions and its 
corresponding primers.  
3.2.3 Strain construction using transformation 
 
Table 3.3 List of Strains Used to Delete Synechocystis genes 
Strain Name Description Parent 
Curtiss 
Collec.  Reference 
SD100 
Synechocystis sp. PCC 6803 single colony 
isolate 
Synechocystis 
sp. PCC 6803 SD100 (115) 
SD277 High free fatty acid producing strain  SD100 SD277 (14) 
SD100 △slr2131 SD100 with △slr2131 :: sacB-KanR  SD100 SD659 this research 
SD277 △slr2131 SD277 with △slr2131 :: sacB-KanR  SD100 SD660 this research 
SD100 △sll0180 SD100 with △sll0180 :: sacB-KanR SD277 SD661 this research 
SD277 △sll0180 SD277 with △sll0180 :: sacB-KanR SD277 SD662 this research 
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Figure 3.1 Electrophoresis gel displaying the DNA fragments created from PCR of using primers 
of either end fragments of sll0180 in (A) SD100, SD100 ∆sll0180, SD100 ∆sll0180 pSacrA and 
(B) SD277, SD277 ∆sll0180, SD277 ∆sll0180 pSacrA. Electrophoresis gel displaying the DNA 
fragments created from PCR using primers of either end fragments of slr2131 in (C) SD100, 
SD100 ∆slr2131, SD100 ∆slr2131 pacrB, SD277, SD277 ∆slr2131, and SD277 ∆slr2131 pacrB. 
Electrophoresis gel displaying the DNA fragments created from PCR of using primers of a region 
within slr2131 in (D) SD100, SD100 ∆slr2131, SD100 ∆slr2131 pacrB, SD277, SD277 ∆slr2131, 
and SD277 ∆slr2131 pacrB.  
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 Versions of the transformation process have been widely used since it was first 
published in 1982 (116). 400ng of p⍦695 was added of 17μL of SD100 at a concentration 
of 1x106 cells/mL. This combination incubates in the illuminated incubator (SANYO) for 
4-5 hours and then was diluted with 50μL of BG-11 liquid media (112), which was then 
plated onto a nitrocellulose membrane that was placed on BG-11 media. Once a visible 
light green patch of cyanobacteria develops, the nitrocellulose membrane was moved to a 
BG-11 plate with 50μg/mL of kanamycin sulfate (Sigma Aldrich, St. Louis, MO) in an 
effort to exchange the sacB-KanR cassette for every sll0180 gene in all 10 to 14 
chromosome copies in each cell. To identify if complete segregation has occurred, the 
primers that encode either end of the flanking regions of sll0180, A 3Z sll0180 end F and 
B 3Z sll0180 end R (Table 3.1), were used with GoTaq PCR reaction and template DNA 
from the colony that was now growing on a BG-11 with Kan media plate. The template 
DNA was obtained by performing a freeze/thaw (-80oC to 55oC) cycle in triplicate of the 
cyanobacteria sample. In Figure 3.1, the first lane of each image is the DNA ladder. The 
ladder is repeated throughout the gels. In Fig. 3.1A, lane 2 in the SD100 native gene 
control of sll0180 and lanes 3 and 4 are SD100 Dsll0180 and SD100 Dsll0180 pacrA, 
respectively, with the A 3Z sll 0180 end F and B 3Z sll 0180 end R primers used in the 
PCR reaction mixture. The primers will work with the other components of the reaction 
mixture to amplify the end each of the flanking regions surrounding sll0180 and amplify 
a ~2,900bp native region or a ~3600bp region that contains the sacB-KanR cassette. 
Important in lanes 3 and 4, there are amplified sequences at ~2,900bp indicating these 
two strains no longer contain the native sll0180 gene. In Figure 3.1B, the same intentions 
of identifying the deletion of sll0180 from strains exist except in SD277 derivatives. In 
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Figure 3.1C, A 3Z slr 2131 end F and B 3Z slr 2131 end R primers were used to identify 
that a ~3,000bp region is present between the 1400bp flanking regions; unfortunately, the 
length of the sacB-KanR cassette and native slr2131 are nearly the same length. So, all 
Figure 3.1C shows is that either the sacB-KanR cassette or the native slr2131 gene is 
located between the flanking regions surrounding slr2131. So in Figure 3.1D, I used a 
different set of primers that only identified the presence ~400bp native nucleotide 
sequence of in the center of the slr2131 gene, 2131 w/in A and 2131 w/in B. The results 
of primers specific to the ~400bp nucleotide sequence for SD100, SD277, SD100 
Dslr2131, SD100 Dslr2131 pacrB, SD277 Dslr2131 pacrB, and SD277 Dslr2131 can be 
seen in Figure 3.1D in which there is no amplified DNA fragment present in any of the 
deletion or complementation strains, while the control strains for each of those, SD100 
and SD277, using the same primers, has the native slr2131 fragment amplified.  Each of 
the negative control, marked as “(-) cntl,” lanes have just dH2O instead of a 
cyanobacterial template. The four strains are referred to throughout this dissertation as: 
SD100 Dslr2131, SD100 Dsll0180, SD277 Dsll0180, and SD277 Dslr2131. All of these 
strains are summarized in Table 3.3 using primers highlighted in Table 3.1.  
3.2.4 Tolerance assays to determine half maximal inhibitory concentrations (IC50) 
 Cyanobacterial strains were grown to mid-log level in BG-11 liquid media (and 
antibiotic if needed). The cyanobacteria were then diluted to half of their current OD730 
(0.35 to 0.4) into 96-well plates (Corning, Corning, NY, USA) containing a concentration 
from 10ng/mL to 10µg/mL of either Amp, Cm, R6G, or erythromycin (Ery) to identify 
the relative IC50 of each strain. The optical density at 790 nm wavelength of each well of 
the plate was read using a plate reader (BioTek, Winooski, VT, USA) initially to verify 
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that each well was in the appropriate density range and then again after 3 days of growth 
at 30oC on a shaker operating at 60 rotations per minute to determine the IC50. The only 
IC50 that was not determined was for Amp as every strain grew uninhibited at a 
concentration of 10µg/mL, so they were subjected to concentrations up to 10mg/mL to 
determine the IC50. The optical density measurements were input into software that 
allows for the production of a non-linear regression curve using the log of the chemical 
concentration versus the cell concentration in 4-parameter variable slope model (Prism 
GraphPad, La Jolla, CA, USA). This identified the IC50 as well as the 95% confidence 
interval of that concentration.  
3.2.5 FFA separation and gas chromatography measurement 
 Each of the six strains used in this chapter are grown to between 8x108 and 1.1x109 
cells/mL in BG-11 liquid media using aeration with humidified, filtered air. 20mL of the 
culture was removed and centrifuged at 6000 x g in an Oak Ridge Centrifuge Tube. The 
entirety of the supernatant was removed and placed into a new Oak Ridge Centrifuge 
Tube. The cell pellet had the intracellular FFA extracted separated from the extracellular 
FFA using a modified Folch Method (117, 118). The Folch method consists of the cell 
pellet was resuspended in 3 mL of a ratio of 2:1 of chloroform:methanol mixture, which 
was vortexed at room temperature for 24 h at low speed. The solvent and resuspended 
pellet mixture was filtered using a PTFE membrane and the resulting solvent was then 
evaporated using a positive nitrogen evaporator (N-EVAP 111, Organomation, Berlin, 
MA) until the sample was dry. To begin processing of both samples (119), the Folch 
extracted sample and the supernatant sample, 10 mL of hexane and 0.2 mL of H3PO4 
were added as a method of direct transesterification. The tubes were then placed on a 
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tabletop orbital shaker at 180 rpm for 30 min at 37oC and then centrifuged at 6000 x g for 
5 min. 1mL of the uppermost layer (hexane layer) was removed and transferred to a glass 
tube (13 x 100mm) and dried on a nitrogen evaporator. The dried sample was then 
dissolved in 1mL of hexane. Then the dissolved sample was analyzed by a gas 
chromatograph (GC) (Shimadzu GC 2010) with a Supelco Nukol capillary column (30m 
x 0.53mm x0.5µm) and flame ionization detector (119). GC operating conditions were as 
follows: split ratio 1:5; inject volume 1 μL; nitrogen carrier gas with constant flow rate 
30 mL⁄ min; H2 40 mL⁄ min, air 400 mL⁄ min, make up gas (nitrogen) 5 mL⁄ min; injector 
and detector temperature 250°C; and oven temperature started at 100°C and increased at 
a rate of 10°C⁄ min to 220°C and held for 10 min. Each FFA compound was identified by 
comparing its retention time with that of a standard of lauric acid, myristic acid, palmitic 
acid, and stearic acid (Sigma Aldrich, St. Louis, MO, USA). Compound concentrations in 
samples were quantified based on the area under the chromatogram peak in comparison 
with the standards. Each sample was run through the gas chromatograph in triplicate and 
the concentration of each FFA present was averaged for the three data points. Each strain 
undergoes this process in triplicate. The four aforementioned FFAs were selected for two 
reasons: the previous research describing the FFA concentrations produced by SD277 
almost entirely consistent of these four chemicals and the genetic modifications that exist 
in the chromosome of SD277 were performed to create lauric acid, myristic acid, palmitic 
acid, and stearic acid. I searched for a number of other saturated and unsaturated fatty 
acids but was never able to measure any besides the four measured. 
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3.3 Results and Discussion 
3.3.1 Mutants have decreased tolerance to most chemical treatments 
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Significant increases in tolerance are highlighted in green.
Table 3.4 IC50 of mutant strains to Ampicillin, Chloramphenicol, Erythromycin, and Rhodamine 6G in which IC50 of  
derivative strain is significantly different than respective parent strain unless otherwise indicated with ns for not significant.  
 SD100 SD100 
Δslr2131 
SD100 
Δsll0180 
SD277 SD277 
Δslr2131 
SD277 
Δsll0180 
Treatment µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL 
Amp 955.2 ± 256 1280 ± 230 (ns) 598 ± 296 1570 ± 170 1001 ± 120 450 ± 119 
R6G 6.08 ± .871 4.03 ± 0.43 4.61 ± 0.51 1.41 ± 0.12 2.59 ± 0.12 0.94 ± 0.27 
Cm 2.290 ± 0.401 0.586 ± 0.142 1.442 ± 0.206 4.749 ± 1.043 1.873 ± 0.354 1.085 ± 0.589  
Ery 0.358 ± 0.081 0.054 ± 0.002 0.172 ± 0.1 0.427 ± 0.249 0.171 ± 0.044 0.034 ± 0.007 
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 The Synechocystis genes, slr2131 and sll0180, were deleted from all 10 to 14 
chromosome copies of both SD100 and SD277, which were verified through colony PCR 
(Figure 3.1). Then each of the four strains now containing a gene deletion were exposed 
to variety of concentrations across multiple log levels of Amp, Cm, Ery, and R6G. The 
IC50 of SD100 Dsll0180 to Amp, Cm, Ery, and R6G is significantly decreased, with 
percent differences of 37%, 37%, 52%, and 12%, respectively, when compared to SD100 
(Table 3.4). A similar, if not more dramatic pattern, is observed in SD277 Dsll0180, 
which possessed a significant decrease of IC50 to Amp, Cm, Ery, and R6G with percent 
differences of 71%, 77%, 92%, and 33%, respectively, when compared to SD277 (Table 
3.4). This follows a similar pattern to another study that inserted a mutation into sll0180 
rendering sll0180 useless in its function to encode Sll0180, in which the researchers 
showed that the mutant strain had an increased susceptibility to SDS, which has been 
shown to be secreted by the AcrAB-TolC pump in multiple species of bacteria (23, 120, 
121). If Sll0180 is required to stabilize the interaction between Slr1270, the outer 
membrane duct, and Slr2131, the multidrug efflux pump, as is the role of an MFP, then 
the lack of the MFP decreases the ability of the cell to move pump substrates to the outer 
membrane duct; and these sets of data highlight the consistent function of Sll0180 with 
that of an MFP. 
 The results from the two strains that lacked slr2131 are more ambiguous (Table 
3.2). SD100 Dslr2131 possessed a significant decreased tolerance to Cm, Ery, and R6G at 
74%, 85%, and 33%, respectively, when compared to SD100 (Table 3.4). However, when 
SD100 Dslr2131 was treated with increasing concentrations of Amp, it was not 
significantly different than wild-type SD100 (Table 3.4). SD277 Dslr2131 had a 
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significant decrease of tolerance to Amp, Cm, and Ery with percent decreases of 36%, 
61%, and 60%, respectively, when compared to SD277 (Table 3.4). Interestingly, SD277 
Dslr2131 had an 84% increase in tolerance to R6G when compared to SD277 (Table 3.4). 
The various modifications to the cell wall of SD277 may prevent R6G from entering the 
cell, but the slr2131 deletion must work in concert with one of the existing SD277 
mutations to the cell membrane structure as SD277 Dsll0180 possesses the expected 
decrease of tolerance to R6G when compared to SD277. 
 To initially generate SD277, the penicillin-binding protein 2 (PBP2) was removed 
from the cyanobacteria. In Staphylococcus aureus, the modification of the gene that 
encodes PBP2 has been shown to increase the minimum inhibitory concentration (MIC) 
of the bacteria when exposed to ceftizoxime, a beta-lactam antibiotic, by way of other 
spontaneous mutations that modify the peptidoglycan cell layer cross linking (122). 
SD277 also has a modified cell wall, losing sll1951, which encodes an S-layer protein. 
SD277 has a 50% greater IC50 to Amp when compared to SD100 (Table 3.4), Amp may 
not be able to diffuse into SD277 as readily as it does into SD100. This may be due to the 
cell membrane modification in SD277. R6G tolerance in SD277 increases when a 
putative multidrug efflux pump, Slr2131, is removed. This was the only case in all of the 
mutant strains were a deletion caused an increase in tolerance to one of the chemicals 
tested. And again, some of the cell membrane modifications may alter the diffusion of the 
chemicals into the cell, but in this case specifically, the lack of Slr2131 may modify R6G 
movement into the cell not observed in either SD277 or SD277 Dsll0180 as both had a 
significantly decreased IC50 to R6G when compared to SD277 Dslr2131 (Table 3.4). I am 
not sure what mechanism would hold R6G out of the cell, but the location of R6G could 
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be identified readily as R6G fluoresces when exposed to a laser beam at wavelength 590 
nm (123). 
 The removal of slr2131 from SD277 may have changed the composition of 
chemical pumps in the membrane. R6G does not have a similar function to the 
antibiotics. R6G does not act on ribosomes or prevent cell wall synthesis like many 
antibiotics. In fact, it has been shown that rhodamine 123, a related dye, can impede 
ATPase activity in the mitochondria of rats (124). If this same event occurs in 
cyanobacteria, then ABC transporters, of which Synechocystis has many described ABC 
import mechanisms (125–129), can be affected. These ABC mechanisms all rely on 
ATPase activity so the removal of slr2131 may have affected the composition or location 
of ABC transporters. At lower concentrations, one of these native ABC transporters is 
unable to pump R6G into the cell due to R6G itself, impeding ATPase activity. This then 
can cause an increased resistance to the dye (130). While I admit this inhibition of 
ATPase activity acting on ABC importers may be far-fetched, the idea that the removal 
of proteins found in the membrane of cyanobacteria causes widespread effects has been 
seen previously. 
 Synechocystis sp. PCC 6803 was shown previously to have 20-fold lower 
permeability to small carbohydrates, inorganic ions, and amino acids when compared to 
E. coli (131). This lack of permeability is likely due to the lack of natural porins in the 
outer membrane of Synechocystis sp. PCC 6803. A recent study hypothesized that the 
most abundant outer membrane proteins of Synechocystis sp. PCC 6803, Slr1841, 
Slr1908, and Slr0042 that make up 80% of the proteins in the outer membrane, are 
primarily responsible for allowing diffusion of inorganic ions into the cell (131). These 
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three proteins are homologs to Synechococcus PCC 6301 proteins, SomA and SomB, 
beta-barrels that allow diffusion and may link the outer membrane to peptidoglycan layer 
(132). The cell needs these ions for basic function; iron is used in the electron transport 
apparatus (133). In E. coli, for example, Amp uses the outer membrane protein F 
(OmpF), a diffusion porin, to navigate its way into the cell (134, 135) at which point it 
interacts with transpeptidase enzyme, inhibiting cell wall synthesis and causing cell lysis 
(136). Without the movement of these ions through the membrane proteins the cells 
struggle to survive, but antibiotics use these same porins to move into the cell, so 
identifying which Synechocystis sp. PCC 6803 porins antibiotics or dyes use to get into 
the cyanobacterial cell will help to uncover the full picture of chemical transport. Amp 
and other antibiotics are designed to be lethal to bacteria but increasing the production of 
chemicals like FFAs can also lead to cell lysis or death if intracellular concentrations 
exceeds the cell tolerance, which may be driven active transport of FFA out of the cell. 
Understanding the flow of chemicals in and out of the Synechocystis sp. PCC 6803 cell is 
paramount to expanding the biotechnology applications of it. 
 
3.3.2 Extracellular and intracellular FFA concentrations are modified in the four mutant 
strains when compared to respective parent strains.  
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 SD277 Dslr2131 and SD277 Dslr0180 presented a significant drop of extracellular 
FFA concentrations when compared to SD277 (Figure 3.2), in which all cells are grown 
to final concentrations 8x108 to 1x109 cells/mL under the same lighting, temperature, and 
aeration conditions. This corroborates my hypothesis that the proteins encoded by sll0180 
and slr2131 affect the ability of SD277 to secrete FFA and the movement of FFA out of 
the cell is not entirely reliant on passive diffusion. In E. coli, FFA secretion is mediated 
by the AcrAB-TolC pump. In E. coli, a mutant strain that has modifications of the acrAB 
and emrAB (encodes two proteins with similar function to acrAB) operons inhibiting 
synthesis of the encoded proteins exhibited significantly less FFA secretion, but this 
secretion function is restored when the mutant strain was complemented with a plasmid 
containing acrAB (21). Of note, when there was just a single mutation of either acrAB or 
emrAB, the mutant E. coli strain did not a possess a significant decrease in extracellular 
FFA concentrations. Researchers hypothesized that the proteins encoded by the emrAB 
and acrAB operons have overlapping functions that can complement one-another with 
respect to FFA efflux. There has not been any published research to determine if the 
removal of acrA or acrB independently of each other will cause the same phenotype with 
respect to FFA efflux in E. coli. In E. coli, the acrA and acrB are located in a 5kb operon 
together facilitating the previously developed acrAB E. coli double mutant, unlike 
slr2131 and sll0180, which are not even in the same orientation in the genome of 
Synechocystis sp. PCC 6803 let alone in an operon together. The emrAB and the mdtAB 
efflux pumps were also removed independently from E. coli, but this combination 
deletion had less of an effect on FFA efflux in E. coli than the acrAB/emrAB double 
operon mutant strain (21). SD277 Dslr2131 had significantly greater intracellular FFA 
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concentration while SD277 Dsll0180 did not have a different intracellular FFA 
concentration when compared to SD277 (Figure 3.3). SD277 Dslr2131 had a significant 
decrease in extracellular FFA concentration (Figure 3.2) and a significant increase in 
intracellular FFA concentration (Figure 3.3) relative to SD277 and, taken in combination, 
this data suggests that the FFAs remained within the cell membrane of the bacteria when 
slr2131 was removed from SD277. This adds further evidence to the hypothesis that 
slr2131 encodes a multidrug efflux pump that has been previously presented (23). The 
sll0180 deletion in SD277 also significantly decreased extracellular FFA concentration 
(Figure 3.2), and the unchanged intracellular FFA concentration (Figure 3.3) relative to 
SD277 further provides evidence that sll0180 encodes an MFP. But besides identifying 
the roles of the proteins encoded by slr2131 and sll0180 there are a couple of other issues 
that were addressed in the SD277 deletion mutants. The first is that the presence of the 
sacB-KanR cassette in the genome of SD277 does not hamper the FFA production as 
intracellular FFA concentration is either unchanged or increased in the two SD277 
mutants relative to SD277 (Figure 3.3). In addition, the lack of either of sll0180 or 
slr2131 genes does not hamper intracellular FFA concentration, so the proteins encoded 
by slr2131 and sll0180 do not have a function with any feedback inhibition mechanisms 
that would work to counteract fatty acid synthesis. Fatty acid synthesis remains as high or 
higher intracellularly in the two mutant strains when compared to SD277 (Figure 3.3), 
which is important in attempting to identify proteins with roles in efflux. If either of the 
SD277 mutants had a decreased intracellular FFA concentration when compared to 
SD277, then the FFA concentration extracellularly would be irrelevant as the lack of the 
gene would have a direct impact on fatty acid synthesis and the impacts of the 
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extracellular FFA concentration could be due to a decrease of FFA production, not efflux. 
Another possible confounding issue is that the SD277 mutants grew at a different rate 
than SD277, varying FFA efflux. According to Figure 3.6 and the corresponding 
statistical tests explained in Chapter 3.2.1, there were no growth rate differences among 
SD277 and its two mutant strains. 
 The results with the SD100 mutant strains are more difficult to arrive at conclusions 
regarding extracellular and intracellular FFA concentrations because both mutants 
produced greater FFA concentrations extracellularly but had no change with respect to 
intracellular FFA concentrations when compared to SD100 (Figure 3.4 and Figure 3.5). I 
do not know why these two deletion mutant strains would have significantly increased 
extracellular FFA concentrations, but the actual average values of the differences 
between the mutants and SD100 are between 3 to 4 mg/L. This is a log level lower than 
the differences displayed in the SD277 mutants when compared to SD277 (Figure 3.2 and 
Figure 3.3) . So, SD100 may just simply not make a high enough concentration of FFA in 
these in-lab, 24 h illuminated growth conditions to further our understanding of FFA 
transportation out of the cyanobacterial cell. SD100 does not make a habit of releasing 
FFA or other energy storage chemicals to its surroundings in which the cyanobacteria 
have to rely on stored energy when the sun sets, as do nearly all photosynthetic 
organisms. The intracellular FFA concentration of the SD100 mutants is unchanged from 
the SD100 parent strain (Figure 3.5), so neither mutation causes an increase of 
intracellular FFA concentration, as was seen in SD277 Dslr2131 (Figure 3.3), but again in 
these 24 h illuminated conditions at the optimal temperature with the perfect balance of 
nutrients and pH, SD100 does not need to store energy for respiration at nighttime in the 
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form of FFAs, as it can make it readily 24 h per day. The two SD100 mutants do not have 
a significantly different growth pattern when compared to SD100 (Figure 3.7), 
illustrating that these two mutations do not have any effect on the growth pattern of 
SD100 or SD277. 
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3.4 Conclusions 
 Mutations in slr2131 and sll0180 in both SD100 and SD277 effectively decrease 
tolerance to antibiotics and R6G, without affecting the growth patterns relative to the 
parent strains (Table 3.4). This is consistent with the hypothesis that sll0180 and slr2131 
encoding an MFP and multidrug efflux pump, respectively. The only exception to this 
conclusion was the tolerance of SD277 Dslr2131 to R6G increased when compared to 
SD277. I am not certain why this was the case. The SD100 Dslr2131 mutant has 
decreased tolerance to R6G, so modifications specific to SD277 in concert with the 
slr2131 mutation may affect how R6G was also able to penetrate the SD277 Dslr2131 
cells, decreasing the rate of R6G diffusion into the cell compared to SD277. The lack of 
the S-layer protein, Sll1951, or the lack of penicillin binding protein 2 (PBP2) may have 
altered the cell wall of the cyanobacteria in a way to slow down the diffusion of R6G into 
the cell, without affecting the antibiotics. But the lack of slr2131 must also affect the 
progression of R6G into the cell in a manner unlike the SD277 strain lacking sll0180.  
 In the high FFA producing, SD277, both proteins encoded by sll0180 and slr2131, 
Sll0180 and Slr2131 are necessary for efficient FFA efflux to the extracellular growth 
medium. Without either of the genes encoding Sll0180 and Slr2131, the concentration of 
all the tested extracellular FFAs decreases (Figure 3.2) while the concentration of 
intracellular FFAs increases or remains the same as SD277 (Figure 3.3), indicating that 
the decrease in extracellular FFA is not due to a decreased production of FFA. In 
addition, growth rates remain consistent, so the decreases are also not due to a slower 
growth rate. 
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 These results when taken together present a perspective on the roles that the Sll0180 
and Slr2131 proteins have in chemical tolerance and FFA secretion through efflux of 
these chemicals. My research has illustrated that Synechocystis sp. PCC 6803 cells use an 
active transportation mechanism similar to E. coli to move FFA and other chemicals out 
of the cell. This is amazing as these two genera separated over 3 billion years ago and 
each has maintained a similar efflux mechanism. The next step in the process of 
understanding the native efflux mechanism of Synechocystis sp. PCC 6803 and 
possibility of added exogenous mechanisms is to add the genes encoding the AcrAB-
TolC pump to increase the tolerance of SD100 and SD277 to the toxic chemicals and 
promote secretion of FFAs in SD277 and SD100, just as adding a plasmid containing 
acrA and acrB promoted FFA efflux in an acrAB/emrAB mutant E. coli strain (21). 
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CHAPTER 4 
THE ADDITION OF ESCERICHIA COLI RESISTANCE-NODULATION-DIVISION 
FAMILY TRANSPORTERS MODIFIES FREE FATTY ACID SECRETION AND 
TOLERANCE TO ANTIBIOTICS AND A DYE 
4.1 Introduction 
4.1.1 Overview and hypotheses 
 This research is an effort to limit the processing costs of producing these precursors 
to biofuels and to enhance the total concentration of the FFAs through the addition of 
exogenous genes expressed in SD277 and SD100. E. coli genes encoding proteins 
responsible for sugar transport have been synthesized in Synechococcus elongatus, a 
closely related cyanobacteria to SD100. The synthesized proteins allowed for transport of 
glucose and lactose in and out of the cell in an effort to permit the cells to grow using 
these sugars at night instead of the stored sugars produced using photosynthesis. This 
chapter looks at the use of the AcrAB-TolC efflux pump from E. coli to export various 
chemicals including intracellularly produced FFAs from SD277 and SD100. No research 
has demonstrated that these E. coli transport proteins can be synthesized in any 
cyanobacterial species. My goal was to increase the extracellular FFA concentration of 
SD277 and demonstrate, in SD277 and SD100, that these proteins can increase the 
tolerance of the cyanobacteria to Amp, Cm, Ery, and R6G. 
 The first hypothesis I test is that adding the gene(s) that encodes individual 
components of the E. coli AcrAB-TolC RND efflux system to SD100 or SD277 will 
increase the tolerance to various antibiotics and R6G. The vectors and strains will be 
briefly discussed here with a more comprehensive explanation of their creation in 
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Chapter 4.2.2. I began with two distinct plasmids each with genetic sequences based on 
the RSF1010 plasmid featuring repA, repB, and repC that each encode a protein that 
promotes appropriate replication in the cell and a Ptrc promoter for constitutive 
expression of the gene ligated downstream of the promoter (137, 138). The only 
difference between the two different RSF1010-based vectors used in this research, pKan 
and pSpec (Appendix A.2), is which an antibiotic-resistance conferring cassette is present 
in the plasmid nucleotide sequence, Kan and Spec, respectively. I created strains that 
would eventually be used as controls in which I added pKan and pSpec separately and 
together to SD100 and SD277 to create the following strains: SD100 pKan, SD100 
pSpec, SD277 pKan, SD277 pSpec, SD100 pSpec pKan, and SD277 pSpec pKan. Then 
the three E. coli genes used in this research, acrA, acrB, and tolC were ligated into pKan 
and pSpec. More specifically, the pSpec plasmid was in which E. coli acrB, acrA and 
tolC genes were located, separately, to create pacrB, pSacrA and ptolC. The pKan 
plasmid was in which E. coli acrA was located to create pacrA. I test my hypothesis that 
adding genes encoding components of the E. coli AcrAB-TolC efflux system to SD100 
and SD277 will increase tolerance to toxic chemicals and will increase the extracellular 
FFA concentrations by individually adding each of the following E. coli plasmids to both 
SD100 and SD277: pacrA, pacrB, and ptolC. This created the following six strains: 
SD100 pacrA, SD100 pacrB, SD100 ptolC, SD277 pacrA, SD277 pacrB, and SD277 
ptolC. Then, I added the combinations of E. coli pacrA and pacrB together and, 
separately, added the combination of E. coli acrA and tolC together to both SD100 and 
SD277 to create the following four strains: SD100 pacrA pacrB, SD277 pacrA pacrB, 
SD100 pacrA ptolC, and SD277 pacrA ptolC. I was never able to isolate strains with 
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acrB and tolC, nor was I able to isolate mutants with all 3 of the genes together in either 
SD100 or SD277. I did not see any significant absolute increase in tolerance to any 
antibiotic with the exception of SD100 possessing pacrA and ptolC. I did see a significant 
increase in tolerance of many derivative strains of SD277 to the R6G, but those effects 
appear to be due to the addition of the plasmid itself as the strains containing plasmid 
controls also possessed significantly increased tolerance to R6G relative to R6G.  
 The second hypothesis I test is that adding the gene(s) that encodes individual 
components of the E. coli AcrAB-TolC RND efflux system to SD277 and SD100 will 
increase the extracellular FFA concentrations in each of the subsequence strains but will 
not change the concentration of intracellular FFAs relative to the respective parent strains 
but will increase the extracellular FFA concentrations. This is achieved using the same 
strains described above but the cells are grown to late-log phase and the supernatant is 
separated from the cells to isolate the FFAs that have been secreted and the remaining 
pelleted cells have the FFAs extracted using the Folch Method (118). None of the 
extracellular FFA concentrations of the derivative strains of SD277 increased 
significantly compared to SD277, but when compared to respective control strains nearly 
all the strains expressing two E. coli genes simultaneously did have increased 
extracellular FFA concentrations relative to the SD277 pKan pSpec control strain. Many 
of the plasmid control vectors possessed a significant decrease in extracellular FFA 
concentrations. The derivative strains of SD100 had far less variation of FFA 
concentrations when compared to the FFA concentration results of SD277 and its 
derivatives. 
4.1.2 The E. coli AcrAB-TolC efflux pump 
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 AcrAB-TolC is a routinely studied multidrug efflux pump in E. coli. It removes a 
plethora of components from the cells, namely antibiotics, dyes, FFAs, and detergents. 
Acriflavine resistance protein B (AcrB) is part of the efflux mechanism of E. coli. As a 
member of the resistance-nodulation-division (RND) superfamily, it functions as a 
proton/substrate antiporter. AcrB is also considered part of a subdivision of RND pumps 
called Hydrophobe/amphiphile efflux-1 (HAE1), which has been identified to export 
numerous drugs, dyes, and detergents including acriflavine, hexane, cyclohexane, Cm, 
Ery, and R6G in E. coli (22, 63, 80, 139, 140). Most importantly for this research, the 
system is also involved in FFA efflux (21). The pump of the system, AcrB, has three 
monomers, each of which has 1049 amino acid residues that together form a trimer to 
span the inner membrane, stabilized via connecting loops. On the periplasmic side, AcrB 
maintains a TolC docking domain and on the opposite side, it possesses a porter domain. 
The PN1 subdomains from each of the three monomers align to form a pore that is too 
small for drugs to pass through. On the opposite site of the monomer, the PC1 and PC2 
domains allow AcrA to dock in a cleft (67). The 397 amino acid residues of AcrA role is 
likely maintaining the interaction of AcrB and TolC so the complex can span the cell 
envelope (141).  
 The monomers of AcrB can take any of three conformations that have been termed 
loose (L), tight (T), and open (O) (142). A substrate binds at the loose conformation, then 
it changes to tight, and finally releases the substrate in the open conformation to the 
waiting channel of TolC that is stabilized by AcrA (143, 144). As opposed to ATP 
synthase, AcrB has a functional rotation, not a physical rotation of monomers (145, 146). 
The three subunits of AcrB do not move in the membrane but instead change 
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conformation, opening and closing of different pockets in the protein to move substrates 
from the cytoplasm to the opening of the outer membrane duct (147). 
 Recognized substrates, such as R6G, will bind to the loose conformation of one of 
the AcrB monomers and that monomer changes to the tight conformation. This 
conformational change of an AcrB monomer does not require energy. Once one substrate 
binds to an AcrB monomer in the loose conformation, a second substrate must bind to a 
different L monomer before the T monomer (of the initial bound substrate) can release 
the chemical via the O monomer. The change from T to O is an energy dependent step, 
relying on ATP hydrolysis and proton uptake from the periplasm (Figure 2.1) (142). 
 TolC is an outer membrane duct. It is anchored to the outer membrane via a b-
barrel, projecting from the outer membrane down into the periplasm (148, 149). It has a 
100Å pore which functions as the exit duct for the AcrB transporter (150). AcrB has 
limited contact with TolC, so AcrA adaptor function is necessary for efficient transfer 
between TolC and AcrB (Figure 2.1) (151).  
 AcrA mediates the interaction between AcrB and TolC. AcrA (150) is 210Å long 
allowing it to span the periplasm (152). This span facilitates the connection between 
AcrB and TolC (153). The N-terminal of AcrA anchors the protein to the inner 
membrane, while also binding to AcrB that is lodged in the inner membrane. This 
combination of interactions stabilizes the AcrA to AcrB connection (Figure 2.1).  
4.1.3 The stresses endured by overproducing FFA 
 When E. coli has been genetically modified to produce substantial quantities of 
FFAs, the cells suffer tremendous physiological stresses. Some of these modifications 
include overexpression of acyl-ACP thioesterases and acetyl-CoA carboxylase (ACC) 
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and/or the deletion of fadD or fadE, that work in the opposite direction of thioesterases 
(31, 154–156). In these modified strains, cells undergo tremendous inner membrane 
stress and altered cell morphology due to the membrane change, leading to an 85% 
reduction in viable cell count (157). 
 FFA production in Synechococcus elongatus also leads to physiological stresses in 
the cells. In a Synechococcus elongatus PCC 7942 strain that possessed similar mutations 
to SD277 in an effort by researchers to create a high FFA-producing strain, the modified 
Synechococcus elongatus PCC 7942 possessed a series of issues including chlorophyll-a 
degradation and changes to localization of phycocyanin and allophycocyanin, indicating 
a stress response in the cells. There are also effects to the lipid composition of the 
membrane (56, 158). The result of this was a decreased rate of cell growth, which may be 
alleviated by an active efflux mechanism in the cell to extrude FFA.  
 In the FFA-producing strain, SD277, that was used as a starting point for the 
research in this study, there was lower cell damage in SD277 cells and an increase growth 
rate when compared to SD100. So, with respect to the SD277 cells, I was not concerned 
about the various stresses on the cells as they had not been observed, but I was interested 
in how the FFAs were secreted for reason highlighted in the following section.  
4.1.4 Natural lipid secretion in cyanobacteria 
  Cyanobacteria possess mechanisms to move lipids out of the cell, yet the 
mechanisms are not well elucidated. The first measurement of lipid movement was 
published in regard to Synechococcus sp. PCC 7942, in which fatty acids were shown to 
move across the thylakoid membrane via diffusion (159). FFA acids are also better able 
to diffuse through the membrane of Synechococcus sp. PCC 7002 when compared to 
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Synechococcus elongatus because of the elevated amount of polyunsaturated FFA that 
promote diffusion (56, 160). FFAs were hypothesized to be moved across the 
phospholipid bi-layer using the “flip-flop” method (14), in which the fatty acids diffuse 
across the membrane where the polar group is supposed to cross through the hydrophobic 
core of the membrane layer, but this rate may be as slow as one molecule per 24-hour 
period due to the energy required for this movement (91, 92).  
 In the previously published research centered on the construction of SD277, the 
added thioesterases synthesized a significant increase of FFA concentration. However, 
the previous research did not separate the supernatant from the growing cells before 
direct transesterification using hexane and phosphoric acid. Instead, researchers relied on 
previous research indicating that hexane and phosphoric acid will not extract FFA from 
within the cell (117). My research looks to identify FFAs located in the supernatant and 
see if the same pattern of FFAs occurs in the supernatant alone. Then the intracellular 
FFA concentrations are also observed.  
 
4.2 Materials and Methods 
 Separate cloning vectors are conjugated into SD100 and SD277. One vector, pKan, 
uses encodes a protein that confers resistance to Kan. The other, pSpec, confers resistance 
to Str and Spec. Initially E. coli genes acrA, acrB, and tolC are placed in SD100 and 
SD277 individually using the aforementioned expression vectors. Then two vectors each 
harboring one of the three genes encoding acrA, acrB, and tolC are placed in the strains 
in different combinations. The only combination that was not successfully created was 
acrB with tolC. In addition, a strain in which all 3 genes were placed in either SD100 or 
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SD277 at the same time was never isolated. These 10 new strains were then used to test 
for survivability on BG-11 plates containing various concentrations of the dye R6G and 
Amp, Cm, and Ery.  
4.2.1 Growth and culture condition 
 The growth and culture collection condition are identical to those explained in 
Chapter 3.2.1; however, if the culture was used for mRNA analysis to identify the 
expression of exogenous E. coli genes in SD100 and SD277 derivatives, another 70mL of 
BG-11 was added to the 30mL culture that was started from a single colony to create a 
100mL culture in a 250 mL Erlenmeyer flask. Once the culture reached the mid-log level 
phase (OD730 of 0.7 to 0.8), two 40mL samples are removed and analyzed for the 
presence of specific mRNA sequences. One sample identified the presence of the E. coli 
gene of interest, while the other sample identified a constitutively expressed 
Synechocystis sp. PCC 6803 gene. For these experiments I chose petB as explained in 
Chapter 4.2.4. 
4.2.2 Construction of expression vector 
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Table 4.1 Primers used to add E. coli genes SD100 and SD277  
Primer Name Sequence Reference 
5' AcrB F CGA TGG ATC CAG TCT TAA CTT AAA CAG GAG C this research 
3' AcrB R AAT TGC ATG CAT AAA AAA GGC CGC TTA CGC  this research 
3' AcrA R ATA TGC ATG CAC GGC TCC TGT TTA AGT TAA  this research 
5' AcrA F GCACGGATCC TTACATATGAACAAAAACAGAGG this research 
5' TolCR GCATGCCATATGTCAGTTACGGAAAGGGTTATGA this research 
3' TolCF GCATGCGGATCCTTGCGGTAGCGGATTCTGCTA this research 
568F GCTAGACAGGCTTATCTTGGAC this research 
568R CGTTGACGAGTATTACCCG this research 
687F TCC TAT GGA ACT GCC TCG GTG AG this research 
687R CGG GAT CGG GAT ACT GGT CGT TAC  this research 
 
 
Table 4.2 List of Plasmids used to Add E. coli Genes to SD100 and SD277 
Plasmid 
Name 
Description Parent Curtiss 
Collec. 
Reference 
pSpec Expression vector conferring resistance to Str 
and Spec 
RSF1010 p⍦568 this 
research 
pKan Expression vector conferring resistance to Kan RSF1010 p⍦687 this 
research 
pacrB Expression vector E. coli acrB p⍦568 p⍦691 this 
research 
pacrA Expression vector E. coli acrA p⍦687 p⍦692 this 
research 
ptolC Expression vector E. coli tolC p⍦568 p⍦699 this 
research 
pRL443 Helper plasmid with methylases RP4 pRL443 (161) 
pRL528 Conjugative plasmid pRL542 pRL528 (161) 
 60 
 The plasmids created for the research described in this chapter are summarized in 
Table 4.2 using primers summarized in Table 4.1. Two vectors that are based on the 
RSF1010 multicopy plasmid containing the repABC operon were the basis for the 
addition of each of the E. coli genes and also represented controls when each of the 
plasmids were added to SD100 and SD277 separately and together. The Ptrc promoter, 
used to constitutively express the downstream gene because is not efficiently repressed 
by SD100 due to the absence of the LacI repressor (162). Ptrc is also located upstream of 
the multiple cloning site region on every plasmid (Figure A.2). None of the native 
promoters of E. coli acrA, acrB, or tolC were used. pSpec elicits resistance to Str and 
Spec using an encoded protein, AadA—streptomycin 3’ adenylyltransferase, that 
prevents the binding of Str or Spec to the 30S ribosomal subunit thus preventing protein 
synthesis (163, 164). pKan elicits resistance to Kan when conjugated into the cell by way 
of the encoded AphA protein, an aminoglycoside transferase. AphA transfers phosphate 
to the hydroxyl group of kanamycin therefore preventing the conventional activity of 
kanamycin, which is to bind to 30S subunit to prevent ensuing protein synthesis (165, 
166). Primers were used to isolate the following genes from the E. coli genome using 
PCR amplification: tolC, acrB, and acrA (Table 4.1). Each primer was designed with 
restriction enzyme cleavage sites at the beginning and end of the amplified nucleotide 
sequence that matches to corresponding cleavage sites already present in the multiple 
cloning region of the pKan and pSpec expression vectors. The primers used to amplify 
tolC are labelled: 5’tolcF and 3’tolcR. The primers used to amplify acrA are labelled: 5’ 
AcrA F and 3’ AcrA R. The primers used to amplify acrB are labelled: 5’ AcrB F and 3’ 
AcrB R. The E. coli genes were isolated from a whole genome preparation (Wizard 
 61 
Genomic Preparation Kit, Promega) of E. coli using iProofTM High-Fidelity PCR Kit 
(Bio-Rad). E. coli gene acrB and pSpec were digested with respective restriction 
enzymes that then allowed the directional ligation of acrB into the now cleaved 
nucleotide sequence of the pSpec vector to create pacrB, while acrA went through the 
same procedure with and be ligated into pKan to create pacrA. 1µL of T4 DNA Ligase 
and 1 µL DNA ligase buffer (NEB) were used in a 10 µL reaction for ligation to proceed. 
tolC was placed in both pSpec to created ptolC. Then each newly created vector was 
introduced into electrocompetent E. coli Top 10 cells (Life Technologies) using a 2.5 kV 
pulse of electricity (Gene Pulser Xcell, Bio-Rad, Hercules, CA). The E. coli Top 10 cells 
containing the vector were grown on a plate containing LB agar media with the 
corresponding antibiotic for selection of the presence of the vector in the E. coli Top 10 
cells overnight at 37oC. Colonies present on the plate the next day were confirmed for the 
presence of the gene using colony PCR in 30µL reaction of DNA polymerase GoTaqÒ 
(Promega). The primers used in the reaction mix to identify the presence of the E. coli 
gene in the correct location are either “568F” and “568R” or “687F” and “687R” (Table 
4.1). The 568F/R set of primers mark sites for amplification on the nucleotide sequence 
from either side of the multiple cloning region of pSpec, while the 687F/R represent 
nucleotide regions to amplify from either side of the multiple cloning region of pKan. If 
the E. coli gene was absent from the region then a 500bp DNA fragment was present 
when the DNA obtained from the PCR reaction is run through DNA gel electrophoresis. 
If the E. coli gene was present in the plasmid, the size of the gene plus 500bp was the size 
of the amplified DNA present on the DNA agarose gel (Table 4.1). The nucleotide 
sequence of the plasmid was also obtained for final confirmation. Any colonies 
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confirmed to have the vector of interest were grown again overnight to allow for isolation 
of the plasmid using a Miniprep Plasmid Purification Kit (Qiagen). The resulting plasmid 
descriptions are summarized in Table 4.2. Then the vector was isolated and it, along with 
pRL528, a helper plasmid that has methylases AvaIIM and Eco47IIM to prevent 
restriction enzyme activity of Synechocystis cells (161, 167), was electroporated into 
electrocompetent Top 10 E. coli cells. The Top 10 E. coli cells with the vectors were 
plated on LB media with antibiotics corresponding to the resistance conferred by the two 
vectors within the cell. A colony PCR using GoTaq DNA polymerase reaction mixture 
(Promega) was used to confirm the presence of the expression vector containing the 
expected E. coli gene.  
4.2.3 Conjugation of cyanobacteria to create strains 
Table 4.3 Strains used to Add E. coli genes to SD100 and SD277  
Strain Name Description Parent Curtiss 
Collec. 
Reference 
SD100 pacrB SD100 p⍦691 (Ec acrB) SD100 SD643 This research 
SD277 pacrB SD277 p⍦691 (Ec acrB) SD277 SD644 This research 
SD100 pacrA SD100 p⍦692 (Ec acrA) SD100 SD645 This research 
SD277 pacrA SD277 p⍦692 (Ec acrA) SD277 SD646 This research 
SD100 ptolC SD100 p⍦699 (Ec tolC) SD100 SD647 This research 
SD277 ptolC SD277 p⍦699 (Ec tolC) SD277 SD648 This research 
SD100 pacrA ptolC SD100 p⍦692 (Ec acrA) p⍦699 (Ec tolC) SD100 SD649 This research 
SD277 pacrA ptolC SD277 p⍦692 (Ec acrA) p⍦699 (Ec tolC) SD277 SD650 This research 
SD100 pacrA pacrB SD100 p⍦691 (Ec acrB) p⍦692 (Ec acrA) SD100 SD651 This research 
SD277 pacrA pacrB SD277 p⍦691 (Ec acrB) p⍦692 (Ec acrA) SD277 SD652 This research 
 
 In order to get the expression vectors varying in size from 7.2kb to nearly 10kb in 
nucleotide lengths into SD277 or SD100, conjugation must be performed to alleviate the 
effects of native restriction enzyme digestion in the cyanobacterial cells using an 
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established method (161, 167). To begin the combination, two groups of E. coli cells 
were grown overnight at 37oC in 15mL liquid LB cultures overnight bearing the 
following vector or sets of vectors: one set of E. coli the expression vector with pRL528 
and conjugal plasmid pRL443 that facilitates the transfer of plasmids between cells. 
pRL443 is an RP4 derivative plasmid that is essential for conjugation of the E. coli gene 
containing plasmid into SD100 or SD277. RP4 (and its derivatives) have two gene 
regions that encode the function of the plasmid: Tra1 and Tra2 (168). Tra1 is composed 
of three operons that encode the primase, relaxase, and leader operon (169). Tra2 is 
composed of 11 operons that are responsible for mobilizing the RSF1010 vector (or 
vector based on RSF1010); RSF1010 is not self-transmissible into a cell (168). 
Simultaneously, 10mL of the cyanobacteria was grown in liquid BG-11 culture to an 
OD730 of 0.4. Then all three sets of cells underwent a washing process in which they were 
centrifuged at 3000 x g for 10 min. The supernatant was poured off and the bacterial 
pellet was resuspended in 10mL of new BG-11 media. This process was repeated two 
more times. After the final wash, the cells were resuspended in 5mL of BG-11. Then a 
control group was created in which 1mL of cyanobacteria was added to 0.5mL of E. coli 
Top cells containing the expression vector with pRL528. Simultaneously, a conjugation 
group was created in which 1mL of cyanobacteria are added to 2mL of E. coli containing 
pRL443 and 2mL of the E. coli cells containing both the expression vector and pRL528. 
These cultures were mixed and then sit for 20 min. Then 400 µL of each of the two 
experimental cell mixtures was spread onto a nitrocellulose membrane that had been 
placed on BG-11+0.5% LB media. This then sat on the lab bench overnight. The next 
morning it was put in a SANYO illuminated chamber at 30oC with light until the plate 
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had a light green lawn (usually after a day or two). Then the nitrocellulose membrane was 
moved to BG-11 with antibiotics corresponding to the resistances specified by the 
expression vector(s) in an effort to select for cyanobacteria colonies containing that 
vector. The antibiotics added to the BG-11 media, kanamycin sulfate, streptomycin 
sulfate, and spectinomcin dihydrochloride pentahydrate, were purchased from Sigma 
Aldrich. Bright green colonies arrived on the nitrocellulose membrane within a week for 
these successfully modified cells. The DNA modifications were confirmed using colony 
PCR using the same primers that were originally used to amplify the nucleotide sequence 
of the E. coli gene from the E. coli chromosome (Table 4.1), in the method described in 
Chapter 3.2.2, to ensure its existence in the cyanobacteria. Subsequently, the 
cyanobacterial cells were grown to the optical density and volume described in Chapter 
4.2.1 to test for the existence of mRNA corresponding to each of the E. coli genes using 
reverse transcriptase-PCR (RT-PCR). I created 14 strains for this chapter including the 
ones with the exogenous genes from E. coli and those containing empty vectors, 
representing controls to ensure the results observed are not solely caused by the addition 
of the vector. The properties of all of these strains are summarized in Table 4.3. 
4.2.4. RT-PCR to identify gene expression 
A 40mL culture was grown to mid-log level phase as explained previously, which was 
then centrifuged at 6000 x g for 10 min to pellet the cells. The supernatant was removed 
and 500 µL of BG-11 media and 1 mL of RNAprotect Cell Reagent (Qiagen) was added. 
Each sample was stored at -20oC until it was ready for RNA isolation. For mRNA 
extraction, the Qiagen RNeasy Kit was used. Briefly, the stored samples were thawed and 
pelleted using a centrifuge at 6000 x g for 10 min. The supernatant was removed, and the 
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pellet was resuspended in 700 µL of RLT Buffer (Qiagen) and transferred to a 2 mL 
locking lid microcentrifuge tubes (Eppendorf, Hamburg, Germany) containing 0.2 g of 
0.25 mm-diameter acid washed glass beads (Sartorius Stedim, Göttingen, Germany). The 
mixture was placed in a Bullet Blender Storm 24 homogenizer (Next Advance, Troy, 
NY) and homogenized for 5 min at the maximum speed. The remaining extraction steps 
were followed exactly as Qiagen recommended. mRNA was quantified using a 
NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific, Waltham, MA). Each 
mRNA sample (1 µg) was treated with one unit of RQ1 RNase-free DNase (Promega) 
according to the manufacturer’s instructions. To create the cDNA, 250ng of RNA was 
transcribed using the Qiagen One-Step RT-PCR Kit in a final reaction volume of 50 µL 
and then placed in the thermal cycler using the manufacturer’s recommendations, using 
primers previously published to identify E. coli genes acrA, acrB, tolC (64) and 
separately a set of primers from previously published work was used to identify petB, a 
constitutively expressed Synechocystis sp. PCC 6803 gene (170), ensuring that mRNA 
was isolated from all cyanobacterial samples. The primers used for RT-PCR analysis are 
summarized in Table 4.4. 
Table 4.4 Primers used for RT-PCR analysis of E. coli genes added to SD100 and SD277 
Primers for RT-PCR Sequence Reference 
petB-F CCTTCGCCTCTGTCCAATAC (170) 
petB-R TAGCATTACACCCACAACCC (170) 
acrA-F CTCTCAGGCAGCTTAGCCCTAA (64) 
acrA-R TGCAGAGGTTCAGTTTTGACTGTT (64) 
acrB-F GGTCGATTCCGTTCTCCGTTA (64) 
acrB-R CTACCTGGAAGTAAACGTCATTGGT (64) 
tolC-F AAGCCGAAAAACGCAACCT  (64) 
tolC-R CAGAGTCGGTAAGTGACCATC  (64) 
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4.2.5 Tolerance Assays to determine half maximal inhibitory concentrations (IC50) 
 The following process is used in Chapter 3. But briefly, each of the strains was 
grown to an OD730 (0.7-0.8) representing a mid-log level growth phase in 10 mL culture 
under aeration, illumination, and at 30oC. The cells were then diluted to an OD790 of 0.40 
and incubated in 96-well plates (Corning) for 3 days in the illuminated incubator 
(SANYO), with each well housing a specific, yet different concentration of each of the 
antibiotics or R6G. The final OD790 was measured using a plate reader (Biotek). The 
results were submitted for analysis using software to determine the non-linear variable 
slope curve that best fits the regression of the concentration of cyanobacteria, indicating 
their tolerance to the antibiotic.  
4.2.6 FFA separation and gas chromatography measurement 
 The processing of each of the strains presented in this chapter follows the exact 
procedure from Chapter 3.2.5 to achieve samples representing intracellular FFA 
concentrations and distinct samples representing extracellular FFA concentration after 
each strain is grown to a final density of 8x108 to 1.1x109 cells/mL. The samples were 
processed using a GC using nitrogen as the carrier gas. The integral of peaks at specific 
time points were then analyzed by being compared to a series of standards that identify 
the time that each peak arrives based on the temperature of the oven in the GC and the 
amount of each sample carrier based on the integral of the peak.  
 
4.3 Results and Discussion 
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4.3.1 Tolerance to toxic chemicals is modified  when genes encoding components of the 
AcrAB-TolC efflux pump are added to SD100 and SD277 
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Significant increases in tolerance are highlighted in green 
Significant increases in tolerance are highlighted in green. 
 
 
Table 4.5 IC50 of Addition Strains to Ampicillin, Chloramphenicol, Erythromycin, and Rhodamine 6G in which IC50 of 
derivative strain is significantly different than SD100 unless otherwise indicated with ns for not significant.  
 SD100 SD100 pacrA 
SD100 
pKan 
SD100 
pacrB 
SD100 
ptolC 
SD100 
pSpec 
SD100 
pacrA 
ptolC 
SD100 
pacrA 
pacrB 
SD100 
pSpec 
pKan 
Treatment µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL 
Amp 955.2 ± 256 
1315 ± 
77 (ns) 
1151 ± 
82 (ns) 
1109 ± 
123 (ns) 
1038 ± 
119 (ns) 
658.6 ± 
88.3 
1705 ± 
154 
914.9 ± 
52.9 (ns) 
516 ± 
78 
R6G 6.08 ± .871 
4.51 ± 
0.7 (ns) 
5.1 ± 
0.6 (ns) 
5.44 ± 
0.34 (ns) 
6.7 ±  
0.8 (ns) 
3.44 ± 
0.58 
7.8 ±  
0.9 (ns) 
7.38 ± 
1.06 (ns) 
6.35 ± 
0.31 
(ns) 
Cm 2.290 ± 0.401 
1.444 ± 
0.114 
1.390 ± 
0.186 
1.976 ± 
0.734 (ns) 
1.93 ± 
0.257 (ns) 
1.653 ± 
0.205 (ns) 
1.781 ± 
0.303 (ns) 
2.004 ± 
1.199 (ns) 
2.571 ± 
0.446 
(ns) 
Ery 0.202 ± 0.02 
0.080 ± 
0.003 
0.072 ± 
0.007 
0.138 ± 
0.080 (ns) 
0.119 ± 
0.026 (ns) 
0.079 ± 
0.005 
0.246 ± 
0.009 
0.334 ± 
0.038 
0.122 ± 
0.086 
(ns) 
Table 4.6 IC50 of Addition Strains to Ampicillin, Chloramphenicol, Erythromycin, and Rhodamine 6G in which IC50 of 
derivative strain is significantly different than SD277 unless otherwise indicated with ns for not significant.   
 SD277 SD277 
pacrA 
SD277 
pKan 
SD277 
pacrB 
SD277 
ptolC 
SD277 
pSpec 
SD277 
pacrA 
ptolC 
SD277 
pacrA 
pacrB 
SD277 
pSpec 
pKan 
Treatment µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL µg/mL 
Amp 1570 ± 
170 
1117 ± 
21 
76.67 ± 
28.5 
118.2 ± 
8.7 
1577 ± 
197 (ns) 
412.6 ± 
34.8 
1615 ± 35 
(ns) 
1126 ± 88 1348 ± 
217 (ns) 
R6G 1.41 ± 
0.12 
3.61 ± 
0.42 
4.91 ± 
0.87 
2.95 ± 
0.13 
4.12 ± 
0.96 
4.06 ± 
0.28 
2.97 ± 0.17 5.44 ± 
3.06 
4.28 ± 
0.34 
Cm 4.749 ± 
1.043 
1.833 ± 
0.390 
1.793 ± 
0.430 
1.984 ± 
0.527 
2.951 ± 
0.23 
2.96 ± 0.4 2.616 ± 
0.525 
6.637 ± 
0.969 (ns) 
1.596 ± 
0.238 
Ery 0.135 ± 
0.03 
0.091 ± 
0.034 
0.149 ± 
0.016 
0.080 ± 
0.008 
0.189 ± 
0.041 (ns) 
0.055 ± 
0.004 (ns) 
0.253 ± 
0.022 
0.166 ± 
0.021 
0.136 ± 
0.011 
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 In Table 4.5 and Table 4.6, I have highlighted significant increases of tolerance 
to chemicals in green when the derivative strain is compared to the parent. The most 
notable picture presented is that there are not many strains possessing increased tolerance 
to Amp, Cm, Ery, or R6G in Table 4.5, representing SD100 and its E. coli gene addition 
derivatives and control strains. The most consistent SD100-based strain that had 
increased tolerance to Amp, Cm, Ery, and R6G was SD100 pacrA ptolC, which had 
greater tolerance to Amp and Ery and no significant difference of tolerance to R6G and 
Cm relative to SD100. The only other SD100 derivative that has increased tolerance 
relative to SD100 was SD100 pacrA pacrB when treated with increasing concentration of 
Ery (Table 4.5). There is no clear pattern that any addition of individual or two of the E. 
coli genes that encode the AcrAB-TolC efflux pump increase the tolerance of SD100 to 
Amp, R6G, Cm, or Ery. 
This lack of increased tolerance to these toxic chemicals is parallelly depicted in 
the SD277 derivative strains with E. coli gene additions or the control vectors (Table 
4.6); however, every derivative strain of SD277 featured in this chapter has an increased 
tolerance to R6G relative to SD277. This increase cannot be attributed to the added E. 
coli genes because the control vector addition provides the same outcome. The only two 
strains that were derivatives of SD277 that possessed increased tolerance to Ery relative 
to SD277 were SD277 pacrA ptolC and SD277 pKan (Table 4.6). Again, this increase 
cannot be attributed to the presence of the E. coli genes in SD277 because pKan caused a 
similar significant increase. This increase in tolerance by the addition of pKan or pSpec is 
not seen in the SD100 derivatives. All SD100-based strains containing a control plasmid 
either do not change or have a decreased tolerance to Amp, Cm, Ery, and R6G relative to 
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SD100 (Table 4.6). To address my concern that the E. coli genes are not being expressed 
in SD100 or SD277, I performed RT-PCR analysis of each strain that contained an 
exogenous gene while using SD100 and SD277 as controls (Figure 4.1). Every strain 
possessed the appropriate mRNA. SD100 and SD277 did not contain tolC, acrA, or acrB 
mRNA, but did possess mRNA encoded by the native gene petB (Figure 4.1). All of the 
E. coli gene addition strains featured in this chapter also possessed mRNA encoded by 
petB. So, the E. coli genes are expressed, yet there exists no tolerance increase to toxic 
chemicals, but the experiment did show that the control vectors modified tolerance. In 
addition, there are no differences in growth rates among any of the derivative strains 
relative to the respective SD100 or SD277 parent strain (Figure 4.6 and Figure 4.7). 
I did not think an expression vector added to a cyanobacteria cell could change 
the tolerance to toxic chemicals, but some research exists indicating that the presence of 
exogenous plasmids can modify resistance to antibiotics. This is not a new phenomenon 
in the world of genetically modifying bacteria. But the basics follow conventional logic. 
Plasmids require a significant amount of energy to maintain in the cell between the 
replication of the DNA and the resulting protein synthesis. This was shown in 1987, in 
which four different pUC8 plasmids were added to E. coli, varying in size from 1.7kb to 
6kb in which researchers noticed that even though the plasmids conferred resistance to 
Amp, that the larger the plasmid, the lower the tolerance to Amp (171). When the 
RSF1050 plasmid was added to E. coli, a relative plasmid to RSF1010—the basis for 
pKan and pSpec (172), the expression rates of the genes located in the plasmids 
decreased as the plasmid copy number increased (173). These pUC8 plasmids did possess 
up to 300 copies in a single E. coli cell (174). The plasmid copy number of pKan and 
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pSpec is likely a single copy per chromosome, which amounts to 10-14 per cell in SD100 
and SD277. We have performed unpublished estimates of copy number in our lab based 
on the quantity of DNA from exogenous plasmids compared to the DNA of the 
chromosome using a colony PCR of the same cyanobacterial sample but with different 
primers, amplifying the same length nucleotide sequence from either the plasmid or the 
chromosome. While this is not as accurate as other methods with actually isolating the 
plasmids from the cells, we certainly learned there is not 300-times the amount of 
plasmid DNA or even 10-times the amount in a cyanobacterial cell.  
 
 
4.3.2 Addition of genes encoding multiple components of the AcrAB-TolC efflux pump 
modifies extracellular and intracellular FFA concentrations 
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  To achieve maximal FFA concentrations, the cyanobacteria cells are grown to 
late-log phase as bacteria do not start to accumulate FFAs in optimal quantities until they 
reach that growth phase. With the addition of these E. coli genes, acrA, acrB, and tolc, 
the goal was to secrete more FFAs than the parent strain. None of the SD277-based 
strains had a higher concentration of extracellular FFAs relative to SD277 (Figure 4.2). 
Neither SD277 pacrA ptolC nor SD277 pacrA pacrB achieved a greater extracellular 
FFA concentration compared to its respective control strain SD277 pKan pSpec (Figure 
4.2). However, SD277 pacrA did not have a modified extracellular FFA concentration 
relative to SD277 pKan, its control strain (Figure 4.2). This lack of difference in 
extracellular FFA concentrations was also seen in SD277 ptolC and SD277 pacrB 
relative to SD277 pSpec.  
 None of the SD277 derivative strains tested had a significantly lower intracellular 
FFA concentration relative to SD277 with the exception of SD277 pSpec (Figure 4.3). 
But both SD277 ptolC and SD277 pacrB, which both contain pSpec which is the parent 
plasmid for the tolC and acrB additions, possessed significantly increased intracellular 
FFA concentrations relative to SD277 pSpec (Figure 4.3). The intracellular FFA 
concentration of SD277 pacrA ptolC is greater than SD277 pKan pSpec, while SD277 
pacrA pacrB is the same as SD277 pKan pSpec. SD277 pKan pSpec has a significantly 
increased FFA concentration intracellularly when compared to SD277 (Figure 4.3). 
However, neither SD277 pKan nor SD277 pacrA have an altered intracellular 
concentration relative to SD277 (Figure 4.3). None of the strains derived from SD277 
varied in growth rates when compared to SD277 (Figure 4.6). Interestingly, SD277 pacrA 
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ptolC, SD277 pacrA pacrB, SD277 ptolC, and SD277 pacrA had a visible oil sheen when 
grown to late log phase that was not observed in SD277 (Appendix A.1) 
The results obtained from SD100 and its derivatives are far simpler to explain. 
SD100 pSpec and SD100 pSpec pKan had significantly increased extracellular FFA 
concentrations relative to SD100, while SD100 pKan was not different than SD100 
(Figure 4.4). SD100 pacrA had a significantly greater extracellular FFA concentration 
than SD100 pKan, but SD100 ptolC was significantly less than SD100 pSpec (Figure 
4.4). SD100 pacrB was unchanged relative to SD100 pSpec with respect to extracellular 
FFA concentrations. Neither SD100 pacrA ptolC nor SD100 pacrA pacrB had 
significantly different extracellular FFA concentrations relative to SD100 pSpec pKan 
(Figure 4.4). None of the intracellular FFA concentrations varied significantly when 
compared to SD100 (Figure 4.5).  
As in Chapter 3, I find it difficult to draw any conclusion from the SD100 
derivative strains because the intracellular FFA concentrations were not modified so the 
plasmids are not affecting native FFA synthesis in SD100. Importantly, the addition of 
the plasmids does not affect the growth rates (Figure 4.7). In addition, the extracellular 
FFA concentrations are either increased or not changed in every derivative strain relative 
to SD100, but I do not see a clear pattern. Some, like SD100 pacrA, increase extracellular 
FFA concentration dramatically compared to SD100 while SD100 ptolC is not different 
(Figure 4.4). The aforementioned results were triplicated so the data is readily 
reproducible. Also, SD100 pSpec has a significantly greater concentration of extracellular 
FFAs, so none of the extracellular FFA concentration increases can be directly attributed 
to the presence of E. coli genes. But I would note that the addition of the plasmids does 
 76 
not hamper FFA efflux in SD100 cells, which is not the case for the SD277 derivative 
strains. The extra FFA synthesis forced in SD277 cells likely has an impact on this result. 
Furthermore, looking at the results of the intracellular FFA concentrations of three 
control strains derived from SD277, the SD277 pSpec strain possessed a significant 
decrease in intracellular FFA production relative to SD277, while SD277 pKan and 
SD277 pKan pSpec were unchanged. However, all three control strains possessed a 
significant decrease in extracellular FFA concentration relative to SD277. But the most 
exciting new to come out of this chapter is that SD277 pacrA ptolC and SD277 pacrA 
pacrB have a significant increase in extracellular FFAs relative to SD277 pKan pSpec, 
which indicates that the E. coli transport genes are encoding proteins that function in 
Synechocystis sp. PCC 6803. If these proteins did not have a role in these SD277 
derivative strains, then I would not expect this increase in extracellular FFA 
concentration. Combining this FFA export evidence with previously established sugar 
transport in cyanobacteria using exogenous proteins leads to a broad picture of all of the 
potential uses of exogenous transport system to move chemicals produced within 
cyanobacteria from the cytoplasm to the extracellular environment.  
 But, this decrease of extracellular FFA concentration of the SD277 control strains 
could be caused by either decreased transportation rate of the FFAs from within the cell 
to the extracellular environment or from the decreased production rate. I suspect this 
decrease is caused by a decreased production rate of FFA therefore limiting the amount 
of substrate that the transport proteins, both native and exogenous, have to use. If the 
transportation rate has been changed through the addition of these plasmids, then I would 
expect to see an increase in intracellular FFA concentration just as observed with the 
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sll0180 or slr2131 mutation strains derived from SD277. But since intracellular is either 
not changed or decreased in the three control strains, the evidence suggests that the 
production of FFA is hampered because of the addition of exogenous plasmids. 
Additionally, there is some previous research findings that corroborate this evidence. 
In numerous bacteria including Bacillus subtilis and Vibrio cholerae, the 
inducible SOS DNA repair system is modulated, in part, by LexA that functions as a 
repressor. Once DNA damage occurs, ssDNA is formed which binds to RecA. This 
combination cleaves the LexA dimer that function as a repressor to the SOS system, 
initiating DNA repair (175). The protein encoded by a lexA homolog in Synechocystis sp. 
PCC 6803, Sll1626, was shown to have a role in down-regulating fab (fatty acid 
biosynthesis) genes in a genetically modified version of Synechocystis sp. PCC 6803 
using some of the same modifications present in SD277 to promote FFA synthesis (176). 
LexA in V. cholerae has been shown to induce the SOS DNA repair response when 
plasmids are conjugated into the cell. The LexA homolog found in Synechocystis sp. PCC 
6803, unlike that in E. coli and V. cholerae, is not linked to any genes involved in DNA 
metabolism in Synechocystis sp. PCC 6803 (177–179). So lexA may not be involved in 
SOS DNA repair in Synechocystis sp. PCC 6803; however, LexA still may be induced by 
exogenous plasmids and has been shown to act directly on genes controlling fatty acid 
biosynthesis in SD277 or Synechocystis sp. PCC 6803. A future study removing lexA 
from the strains created for this research may help illustrate a picture of involvement not 
only, in fatty acid biosynthesis but may help explain the decrease FFA concentrations in 
SD277 control derivative strains containing exogenous plasmids lacking the E. coli 
transport genes. Importantly, my research has linked the addition of exogenous plasmids 
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to a decrease in production of FFAs in SD277. In addition, now that this research has 
established efficacy of E. coli acrA and acrB genes in the cyanobacterial cell, placing the 
entire E. coli multidrug efflux system in the cells simultaneously (AcrAB-TolC) may 
increase FFA concentration extracellularly. 
The nucleotide sequence identity of sll0180 to E. coli acrA is not as great as the 
identity of slr2131 and slr1270 is to E. coli acrB and tolC, respectively. sll0180 is as 
close a homolog that the cyanobacteria possess, yet the open reading frame is about 40% 
longer than that of acrA, while slr1270 and slr2131 share far more similarities to their 
homologous acrB and tolC, respectively. Each have genes that are far closer in size and 
sequence, with resulting proteins, in the case of Slr1270, that fold and function in the 
same manner as TolC in E. coli (60). Each of these E. coli genes used in this chapter were 
placed under the control of a Ptrc promoter that is not inducible or repressible. Having an 
inducible promoter may benefit the total FFA efflux. In Salmonella enterica, a closely 
related bacteria to E. coli, the expression of acrAB is subject to active regulation by 
OmpR that binds to promoter sites of each gene (180). While growth rates of the strains 
do not change (Figure 4.6 and Figure 4.7), the synthesis of the efflux proteins may need 
to be modulated for optimal efficacy. 
Other researchers have used transporters to successfully secrete FFA. In a high 
FFA producing E. coli strain, researchers were able to secrete 110 mg/L of FFA into the 
extracellular environment using a modified expression level of E. coli MsbA transporter 
mRNA (181). Until this study, no reports had existed of MsbA being used in FFA 
transport. This increase was 20 times over the control strain that was performed by using 
4 genetic modifications to promote FFA production. These FFA producing modifications 
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included the addition of tesA and AtFatA, both of which are thioesterases as described 
previously in Chapter 3. Also, fadD and fadL were removed as the proteins synthesized 
from the genes facilitate uptake of long chain FFA, which would reverse the secretion. 
It’s surprising that the secretion of a few of the strains created in this research is 
comparable to that of a genetically modified E. coli. The maximum secretion of total 
FFAs achieved with a SD277-based strain in this chapter was between 40 and 42 mg/L, 
about half of the concentration shown in E. coli. It should be considered that other E. coli 
strains have been shown to make in the range of 8.6 g/L of FFA through various genetic 
engineering modifications (182), compared to the 197 mg/L observed in SD277 when the 
entire cell and supernatant is processed for FFA concentration (14). But to increase the 
efficiency of biofuel productions, the cells need to be growing continuously. While the 
8.6 g/L measured in a genetically modified E. coli strain is a far greater concentration of 
FFA when compared to SD277, the FFAs are only accessible after the FFAs have been 
extracted from the E. coli. When comparing extracellular FFA concentrations, the 
maximal achieved concentration when comparing SD277 to a genetically modified E. 
coli strain is in the same log level, so my research in this dissertation is an important step 
to understanding how to efficiently move FFA out of the cell. 
In a similar study, trying to retrieve secreted FFA from a continuously growing E. 
coli strain that was engineered to have the genes encoding the acyl-ACP from 
Umbellularia californica (fadD, fadE, and fadAB) placed in the chromosome repeatedly, 
which would allow the encoding of a protein that would compete with FFA synthesis. 
The goal was to produce an E. coli with a high FFA yield with an antibiotic-resistance 
carrying plasmid present. They achieved slightly more than 200 mg/L of lauric acid and 
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palmitic acid in the collected foam that forms from the growth of the bacteria (183). 
Again, this is in the same log level concentration of the FFAs observed in SD277. So, 
cyanobacteria are not at an immense disadvantage is extracellular FFA concentrations, 
but instead cyanobacteria are nearly identical to observed E. coli levels. Combine this 
information with the idea that cyanobacteria can be grown outside with limited nutrients 
added to the growth medium and the industrial relevance of these modified cyanobacteria 
is evident. 
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4.4 Conclusion 
 Tolerance to various antibiotics was not increased universally. Only SD100 pacrA 
ptolC possessed a significant increased tolerance to Amp, while SD100 pacrA pacrB and 
SD100 pacrA ptolC had a significant increase of tolerance to Ery. All SD277-based 
strains possessed an increased tolerance to R6G, but it was not due solely to the addition 
of the E. coli genes as all of the plasmid vectors had a significantly increased tolerance to 
R6G. SD277 pKan and SD277 pacrA ptolC both had increased tolerances to Ery, but this 
again only indicates that the tolerance is not due to the addition of the E. coli genes in the 
SD277-based strains. 
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 Some informative results were delivered when the concentration of extracellular 
FFAs were measured. Both SD277 pacrA ptolC and SD277 pacrA pacrB possessed a 
significant increase in extracellular FFA concentrations relative to SD277 pSpec pKan, 
indicating that all three E. coli transport proteins function in Synechocystis sp. PCC 6803. 
SD277 tolC and SD277 acrB possessed statistically the equivalent extracellular FFA 
concentrations compared to SD277 pSpec, while SD277 acrA and its vector control 
possessed the same pattern. The intracellular FFA measured in this chapter were either 
statistically identical to SD277 or increased with one exception: SD277 pSpec. These 
results presented the possibility that the plasmid may be affecting FFA production itself, 
which may be governed by a LexA homolog in SD100 (and SD277).  
 The most important piece of information garnered from this chapter is that these 
E. coli efflux genes can be expressed in SD100 and SD277, compensating for the 
negative effects that the addition of the plasmids creates with respect to FFA production 
and tolerance to toxic chemicals. This information can be used to further the study of 
using exogenous transporter in SD277 including in Chapter 5 of this dissertation.  
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CHAPTER 5 
COMPLEMENTATION OF THE REMOVED SYNECHOCYSTIS SP. PCC 6803 
TRANSPORT GENES WITH HOMOLOGOUS ESCERICHIA COLI GENES 
FURTHER MODIFIES THE FREE FATTY SECRETION AND TOLERANCE TO 
ANTIBIOTICS AND A DYE 
5.1 Introduction 
5.1.1 Outline and hypotheses 
 In Chapter 3, some lethal effects of the deletions of slr2131 and sll0180 from 
SD100 and SD277 were observed when the mutant strains were grown in the presence of 
antibiotics and R6G. This chapter seeks to address this by adding the homologous E. coli 
gene to complement the mutations, using the plasmids developed in Chapter 4. In many 
studies examining the effects of the removal of RND efflux pumps, researchers remove 
the genes of interest and then add them back to the bacteria using an expression vector. I 
use this same complementation strategy in this chapter. The removal of slr2131 and 
sll0180 from SD277 decreased the concentrations of extracellular FFA and increased the 
intracellular FFA concentrations. Subsequently, the opposite occurred by the removal of 
slr2131 and sll0180 from SD100 in which the extracellular FFA concentrations 
increased, but intracellular concentrations were unchanged. The tolerance to toxic 
chemicals mostly decreased in the mutant strains when compared to the respective parent 
strains. 
 I hypothesize that the addition of pacrB to SD100 Dslr2131 and SD277 Dslr2131 
and the addition of pSacrA to SD100 Dsll0180 and SD277 Dsll0180 will restore the 
decreased IC50 that occurred when the original deletion mutants were treated with various 
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concentrations of Amp, R6G, Cm, and Ery as observed in Chapter 3. In addition, I 
hypothesize that the addition of pacrB to SD277 Dslr2131 and pSacrA to SD277 
Dsll0180 will significantly increase extracellular FFA concentrations and decrease 
intracellular FFA concentrations compared to their respective deletion mutant parent 
strains. I also think that the addition of pacrB to SD100 Dslr2131 and pSacrA to SD100 
Dsll0180 will not modify the intracellular or extracellular FFA concentrations. 
5.1.2 Using complementation of E. coli acrAB mutants with E. coil acrAB to study the 
function of the AcrAB proteins 
 When E. coli acrAB/emrAB mutants were shown to lack the FFA secretion abilities 
of a wild-type E. coli, the researchers were able to add the wild-type acrAB genes back to 
the mutant E. coli and restore the FFA efflux function (21). In addition, when the E. coli 
AcrA protein was rendered nonfunctional using a deletion of the E. coli acrA gene, the 
ability of the AcrAB efflux pump to promote tolerance to Ery, Cm, tetracycline, crystal 
violet, ethidium bromide and other toxic chemicals in the acrA mutant E. coli strain was 
significantly decreased (140). The tolerance to the aforementioned chemicals was 
restored in the acrA deletion mutant E. coli cells was restored when the E. coli wild-type 
acrA gene was complemented into the acrA deficient strain using a plasmid vector 
containing the nucleotide sequence of E. coli acrA (152). The same restoration of 
tolerance to the numerous toxic chemicals mentioned previously was found in an acrB 
deficient E. coli strain when a plasmid containing E. coli acrB was conjugated into the 
acrB deficient strains (184). 
 I followed a similar complementation model using the following previously 
discussed mutant strains: SD100 Dslr2131, SD277 Dslr2131, SD100 Dsll0180, and 
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SD277 Dsll0180. However, instead of adding the cyanobacterial gene that was removed 
back to the mutant strain by way of a conjugative plasmid, I added the homologous E. 
coli gene, either E. coli acrB and acrA. E. coli acrB was added using a conjugative 
plasmid to transfer wild-type allele to the two strains containing slr2131 mutations, 
SD100 Dslr2131 and SD277 Dslr2131, while the wild-type E. coli acrA gene was added 
using a conjugative plasmid to transfer the wild-type gene to the two strains containing 
sll0180 mutations, SD100 Dsll0180 and SD277 Dsll0180. 
 
5.2 Materials and Methods 
5.2.1 Growth and culture conditions 
 The same culture and growth conditions were used for the research in this Chapter 
as described in Chapter 3.2.1 accompanied by the further detail of the sample preparation 
for mRNA analysis described in Chapter 4.2.1. 
5.2.2 Strain Construction using Conjugation 
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Table 5.1 List of Plasmids Used for Complementation 
Plasmid 
Name 
Description Parent Curtiss 
Collec. 
Reference 
pacrB Expression vector E. coli acrB p⍦568 p⍦691 this research 
pSacrA Expression vector E. coli acrA p⍦568 p⍦692 this research 
pRL443 Helper plasmid with methylases RP4 pRL443 (161) 
pRL528 Conjugative plasmid pRL542 pRL528 (161) 
     
Table 5.2 List of Strains Used for Complementation 
Strain Name Description Parent Curtiss 
Collec. 
Reference 
SD100 △slr2131 pacrB SD100 with slr2131 deleted with 
expression vector encoding E. coli acrB 
SD100 △slr2131 SD665 this research 
SD277 △slr2131 pacrB SD277 with slr2131 deleted with 
expression vector encoding E. coli acrB 
SD277 △slr2131 SD666 this research 
SD100 △sll0180 pSacrA SD100 with sll0180 deleted with expression 
vector encoding E. coli acrA 
SD100 △sll0180 SD667 this research 
SD277 △sll0180 pSacrA SD277 with sll0180 deleted with expression 
vector encoding E. coli acrA 
SD277 △sll0180 SD668 this research 
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 I created a new plasmid for the research in this chapter, pSacrA. In Chapter 4, E. 
coli acrA was ligated in pKan, but I needed acrA on a vector with Spec and Str resistance 
because all four mutant strains are resistant to Kan. This new plasmid was created in the 
same protocol using the same primers from Table 4.1, including the combination of 
pSacrA and pRL528 into the same E. coli Top 10 cell as described in Chapter 4.2.2. The 
plasmids for this chapter are summarized in Table 5.1. Then pSacrA was conjugationally 
transferred into SD100 Dsll1080 and SD277 Dsll1080, while pacrB was conjugationally 
transferred into both SD100 Dslr2131 and SD277 Dslr2131 using the conjugation 
procedure outline in Chapter 4.2.3. Briefly, 10 mL cultures of the mutant strain of 
cyanobacteria were grown to early log phase (OD730 of 0.4), while 15 mL cultures of E. 
coli Top 10 cells containing the expression vector with pRL528 were grown overnight in 
liquid LB containing appropriate antibiotics at 37oC of the following strains alongside an 
E. coli culture containing pRL443. After washing each of the three cultures with BG-11, 
they were combined to allow the conjugation to proceed. After a 20-minute room-
temperature incubation, 400 µL of the combination of the three cultures was placed on a 
nitrocellulose membrane that was resting on a BG-11 with 0.5% LB media added and 
incubated in the illuminated chamber (SANYO). A control combination of cultures was 
also used, in which no E. coli Top 10 cells with pRL443 were added to the other two 
cultures. Once a faint green color arose on the surface of the nitrocellulose membrane, the 
membrane was then transferred to a plate containing BG-11 with 40µg/mL of Kan and 
30µg/mL each of Spec and Str to select for the presence pacrB or pSacrA and 
maintenance of the cassette conferring resistance for Kan in the cyanobacterial 
chromosomes that was exchanged for slr2131 or sll0180. Individual colonies arose within 
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seven days and were picked off of the nitrocellulose membrane using a sterilized loop 
and patched onto a new BG-11 plate containing the aforementioned concentrations of 
Kan, Spec, and Str. The presence of the E. coli DNA and mRNA was tested using 
conventional PCR and RT-PCR as described in Chapters 4.2.3 and 4.2.4 using primers 
and plasmids highlighted in Table 4.1 and Table 4.2, respectively. The primers used for 
RT-PCR analysis are described in Table 4.4 for each of the two E. coli genes and the one 
SD100 gene used as a control in addition to petB from SD100 being used as an RNA 
control to ensure that RNA was being appropriately isolated. A conventional PCR was 
also performed using the DNase treated purified RNA samples from each of the strains 
described in this chapter. There was no DNA found in any RNA sample. The descriptions 
of resulting strains are summarized in Table 5.2. 
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5.2.3 Tolerance Assays to determine half maximal inhibitory concentrations (IC50) 
 The same process was used in this chapter as was described in Chapter 3.2.4. But 
briefly, each of the strains was grown to a mid-log level growth phase. The cells were 
then diluted to an OD790 between 0.35 to 0.40 in 96-well plates (Corning) using various 
concentrations of Amp, R6G, Cm, and Ery, and grown for 3 days in the illuminated 
incubator (SANYO). The final OD790 was measured using a plate reader (Biotek). The 
measurements were analyzed using GraphPad Prism 6 software to determine the non-
linear variable slope curve that best fits the regression of the concentration of 
cyanobacteria compared to the concentration of chemical, indicating their IC50 to the 
chemical.  
5.2.4 FFA separation and gas chromatography measurements 
 The analysis of intracellular and extracellular FFA concentrations of each of the 
strains presented in this chapter follows the exact procedure from Chapter 3.2.5 by 
growing a 30 mL culture each strain to a final density of 8x108 to 1.1x109 cells/mL. Then 
the 20 mL of the culture of cyanobacteria was centrifuged, and the supernatant was 
removed from sample. The remaining pelleted cyanobacterial cells were resuspended in 3 
mL of a 2:1 ratio of chloroform:methanol to follow the protocol of a modified Folch 
method for FFA extraction (117). Once the Folch method extracted sample was filtered 
and the resulting solvent was dried using a positive nitrogen evaporator, the sample was 
treated using the process of direct transesterification using the addition 10 mL hexane and 
200 µL phosphoric acid. The addition 10 mL hexane and 200 µL phosphoric acid was 
also used to perform the process of transesterification in the supernatant collected from 
the initial centrifugation of the 20 mL culture. Each of the samples were processed using 
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a GC using nitrogen as the carrier gas. The peaks at specific time points are then analyzed 
for the area under each identified peak and comparing them to a series of standardized 
peaks. 
 
5.3 Results and Discussion 
5.3.1 Tolerance to Cm is restored in SD100 Dslr2131, SD277 Dslr2131, SD100 Dsll0180, 
and SD277 Dsll0180 mutant strains when homologous E. coli gene is added relative to 
respective parent strain (SD100 or SD277). 
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Table 5.3 IC50 of Ampicillin, Chloramphenicol, Erythromycin, and Rhodamine 6G of 
SD277-Based Complementation Strains in which IC50 of derivative strain is 
significantly different than SD277 unless otherwise indicated with ns for not 
significant.  
 SD277 SD277 
Δslr2131 
SD277 
Δslr2131 
pacrB 
SD277 
Δsll0180 
SD277 Δsll0180 
pSacrA 
Treatment µg/mL µg/mL µg/mL µg/mL µg/mL 
Amp 1570 ± 
170 
1001 ± 
120 
980.3 ± 
37 
450 ± 
119 
286.6 ± 113.8 
R6G 1.41 ± 
0.12 
2.59 ± 
0.12 
1.48 ± 
0.05 (ns) 
0.94 ± 
0.27 
.18 ± .05 
Cm 4.749 ± 
1.043 
1.873 ± 
0.354 
3.305 ± 
1.100 (ns) 
1.085 ± 
0.589  
3.486 ± 1.027 (ns) 
Ery 0.427 ± 
0.249 
0.171 ± 
0.044 
0.095 ± 
0.007 
0.034 ± 
0.007 
0.075 ± 0.014 
Restored tolerance is highlighted in green. 
      
Table 5.4 IC50 of Ampicillin, Chloramphenicol, Erythromycin, and Rhodamine 6G of 
SD100-Based Complementation Strains in which IC50 of derivative strain is 
significantly different than SD100 unless otherwise indicated with ns for not 
significant.  
 SD100 SD100 
Δslr2131 
SD100 
Δslr2131 
pacrB 
SD100 
Δsll0180 
SD100 Δsll0180 
pSacrA 
Treatment µg/mL µg/mL µg/mL µg/mL µg/mL 
Amp 955.2 ± 
256 
1280 ± 
230 (ns) 
891 ± 117 
(ns) 
598 ± 
296 
577.0 ± 23.2 
R6G 6.08 ± 
.871 
4.03 ± 
0.43 
3.94 ± 
0.79 
4.61 ± 
0.51 
1.80 ± .13 
Cm 2.290 ± 
0.401 
0.586 ± 
0.142 
2.124 ± 
1.004 (ns) 
1.442 ± 
0.206 
4.73 ± 1.47 
Ery 0.358 ± 
0.081 
0.054 ± 
0.002 
0.103 ± 
0.019 
0.172 ± 
0.1 
.144 ± .028 
Restored tolerance is highlighted in green. 
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 SD100 Dslr2131 and SD100 Dsll0180 possessed significantly lowered tolerances to 
Cm than did SD100 and similarly, and SD277 Dslr2131 and SD277 Dsll0180 possessed 
significantly lowered tolerances to Cm than did SDSD277 (Chapter 3). The tolerance of 
SD100 Dslr2131 pacrB, SD277 Dslr2131 pacrB, SD100 Dsll0180 pSacrA, and SD277 
Dsll0180 pSacrA to Cm increased significantly compared to their parental (deletion 
mutant) strains to the point that each of the four complemented strain listed above are 
statistically the same as for SD100 and SD277 (Table 5.3 and Table 5.4). While, the IC50 
of SD100 Dslr2131 pacrB, SD277 Dslr2131 pacrB, and SD277 Dsll0180 pSacrA did not 
surpass that of the respective control strains, SD100 and SD277, each had the equivalent 
tolerance to Cm as did SD100 and SD277 (Table 5.3 and Table 5.4). SD100 Dsll0180 
pSacrA, on the other hand, did have a significantly greater tolerance to Cm when 
compared to SD100 (Table 5.4). SD277 Dslr2131 pacrB possessed a statistically 
unchanged IC50 to Amp and Ery when compared to SD277 Dslr2131 and both sets of 
strains had statistically lower tolerance to Amp and Ery when compared to SD277 (Table 
5.3). When SD100 Dslr2131 pacrB was treated with Ery, it possessed a significantly 
greater IC50 when compared to SD100 Dslr2131, but still statistically less than SD100 
(Table 5.4). SD277 Dsll0180 pSacrA possessed significantly decreased tolerances to Amp 
and R6G but an increased tolerance to Ery relative to SD277 Dsll0180 (Table 5.3). 
SD100 Dsll0180 pSacrA also had a decreased tolerance to R6G but the same tolerance to 
Amp and Ery relative to SD100 Dsll1080 (Table 5.4). SD100 Dslr2131 pacrB had 
statistically the same IC50 when treated with increasing concentrations of R6G as did 
SD100 Dslr2131, both of which are significantly less than SD100 (Table 5.4). pacrB did 
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not restore R6G tolerance in the SD100 Dslr2131 mutant strain. SD277 Dslr2131 had an 
increased tolerance to R6G; when SD277 Dslr2131 was complemented with the wild-
type E. coli acrB allele, the tolerance of the resulting strain fell to statistically identical 
levels as observed for SD277 (Table 5.3). All of the expected E. coli genes were 
expressed in the appropriate strains (Figure 5.1), while SD100/SD277 petB mRNA was 
also observed using RT-PCR analysis for all strains (Figure 5.2).  
 Neither the lack of expression of the E. coli gene in the cyanobacterial strain nor the 
growth rate of the strain provides any insight into why the tolerance to Ery, Amp, and 
R6G is not significantly improved when a wild-type E. coli gene are added to the four 
mutant strains of SD100 and SD277. The one consistent piece of information drawn for 
the IC50 assays in this chapter is that the tolerance to Cm can be restored by the addition 
of homologous E. coli genes to SD100 and SD277 strains lacking native sll0180 and 
slr2131 genes. The remaining data does not indicate that the proteins encoded by acrA 
and acrB have a substantial role in conferring tolerance to toxic chemicals in mutant 
strains of SD100 and SD277 when sll0180 or slr2131 are removed from the 
cyanobacteria. This could be a result of the inability of AcrA or AcrB to interact with 
native proteins involved in transport within Synechocystis sp. PCC 6803. For example, 
AcrA may not function with Slr1270 (TolC homolog) and Slr2131 (AcrB homolog) to 
facilitate the movement of the antibiotics or R6G from Slr2131 to the Slr1270 outer 
membrane duct as seen in E. coli where the structure and interactions of proteins is 
critical to the observed phenotype of an operational AcrAB-TolC efflux pump (141, 148, 
185, 186). This potential lack of an interaction of AcrA with native Slr2131 and Slr1270 
is investigated further in the following section. 
 94 
 
5.3.2 The addition of acrB increases FFA secretion 
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 SD277 Dslr2131 pacrB possessed a significantly greater extracellular and 
intracellular FFA concentration compared to SD277 (Figure 5.3). SD277 Dslr2131 pacrB 
also possessed a greater concentration of extracellular FFAs compared SD277 Dslr2131, 
but the same concentration of intracellular FFAs. SD277 Dsll0180 pacrA possessed the 
same concentration of extracellular FFA compared to SD277 Dsll0180, so both possessed 
significantly less extracellular FFA concentration compared to SD277. SD277 Dsll0180 
pacrA had a decreased intracellular FFA concentration relative to SD277 Dsll0180 while 
there was no difference between the intracellular FFA concentrations of SD277 Dslr2131 
pacrB and SD277 Dslr2131 (Figure 5.4). The addition of pacrA to SD277 Dsll0180 did 
assist in FFA efflux, but the opposite was true when pacrB was added to SD277 
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Complementation Strains where ns is not significant
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Dslr2131. The addition of wild-type E. coli gene acrA and acrB to SD100 Dsll0180 and 
SD100 Dslr2131, respectively, either decreased the extracellular FFA concentration 
relative to the mutant strain or the concentration remained the same (Figure 5.5). None of 
the intracellular FFA concentrations of SD100 and its derivatives varied (Figure 5.6). 
None of the mutant or complemented strains have any significant variation in growth 
patterns relative to their respective SD100 or SD277 parent strains (Figure 5.7 and Figure 
5.8). All of the expected E. coli genes were expressed in the appropriate strains (Figure 
5.1), while SD100/SD277 petB mRNA was also observed using RT-PCR analysis for all 
strains (Figure 5.2).  
 SD277 Dslr2131 pacrB possessed the highest concentration of extracellular FFAs 
of any strain in this research. The addition of the wild-type E. coli acrB to SD277 
Dslr2131 counteracted the detrimental effects observed in the extracellular FFA 
concentration of SD277 Dslr2131. The extracellular FFA of SD277 Dslr2131 pacrB was 
so high that it possessed a significant increase of extracellular FFA concentration 
compared to SD277. If Slr2131 is a multidrug efflux pump, responsible for FFA efflux, a 
deletion of the gene encoding that pump (slr2131) would almost certainly cause a 
decrease in extracellular FFA concentrations (Figure 5.3). Furthermore, the wild-type E. 
coli acrB allele was present in the cell, as revealed by synthesis of mRNA (Figure 5.1). 
Data from Chapter 4 shows that the addition of pacrB to SD277 does not increase the 
extracellular FFA concentration, but the increase observed here must be due to the 
presence of the E. coli AcrB protein in the membrane of SD277, exchanging protons for 
FFA substrates. As was seen in Chapter 4, the addition of the parent plasmid of pacrB, 
pSpec, did not increase the FFA concentration of SD277 therefore, the increase seen here 
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can only be attributed to the encoded AcrB protein in SD277 Dslr2131 pacrB. 
Interestingly when only pacrB was added to SD277 there was not an increase in 
extracellular FFA but there was when pacrB was added to SD277 Dslr2131 relative to 
SD277, indicating a number of conclusions. First, the native Slr2131 efflux pump must 
not be in place for the optimal operation of E. coli AcrB, likely because AcrB uses the 
same Slr1270 outer membrane duct as Slr2131 would use in its native configuration. 
There have been previous experiments indicating the role of Slr1270 and the likelihood 
that it functions in a similar manner to TolC (60, 61). This is all important because the 
results indicate that E. coli AcrB can work with Slr1270 to increase extracellular FFA 
concentrations through FFA export. This opens up an interesting opportunity for future 
research to look into how to further promote FFA efflux and production by modifying 
native transport systems or introducing exogenous ones now that it’s clear that a native 
active efflux system is used to move FFA out of Synechocystis sp. PCC 6803 derived 
strains’ cells and exogenous genes can be used to compensate for the loss-of-function 
created by removing the native active efflux system. 
 Conversely, the addition E. coli acrA was not able to compensate for the loss-of-
function with respect to FFA export of SD277 Dsll0180. E. coli AcrA may just not 
effectively recognize binding sites on the Slr1270 outer membrane duct or there may 
exist differences in the membrane structure of these cyanobacteria that may not be ideal 
or even necessitate AcrA. AcrA is created from 397 amino acids while Sll0180 is 
composed of 501 amino acids. When comparing the homology of the two proteins, the 
first 131 amino acids of Sll0180 share an 18% identity to AcrA and, similarly, nearly the 
last 262 amino acids of Sll0180 share a 19% identity to AcrA (Sll0180 amino acids 500 
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and 501 were not included in this identity analysis) (110). But this leaves the gap from 
amino acids 132 to 237 in Sll0180, bearing virtually no homology to AcrA. When 
identifying possible protein binding regions in these 105 nonhomologous amino acids, 
two are predicted at sites 132 and 183. AcrA does not possess this central region that is 
present in Sll0180 and the region may affect the ability of AcrA to bind to a protein 
within the membranes of Synechocystis sp. PCC 6803. In addition, previous research has 
supported the hypothesis that the periplasmic end of the Slr1270 outer membrane duct in 
Synechocystis sp. PCC 6803 remains open without the MFP, which is not the case for E. 
coli TolC lacking an MFP. Without E. coli AcrA or a different MFP, the periplasmic end 
of E. coli TolC collapses, while Slr1270 maintains its open at both ends of the duct 
without an MFP (60). Based on the results of the sll0180 mutant strains, the Sll0180 MFP 
is necessary for a native efflux mechanism, but the resulting loss of function cannot be 
compensated through the addition of E. coli AcrA in SD100 or SD277 sll0180 mutant 
strains. The compounding differences between Sll0180 and AcrA including the amino 
acid sequence lengths (501 compared to 397), nonhomologous protein binding sites, and 
the different roles each may have in relation to the outer membrane duct may all lead to 
the inability for E. coli AcrA to restore the loss of function demonstrated in sll0180 
mutant SD100 and SD277 strains with respect to FFA secretion and tolerance to Amp, 
Cm, and Ery. 
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5.4 Conclusion 
 The tolerances of SD100 Dslr2131 pacrB, SD277 Dslr2131 pacrB, SD100 Dsll0180 
pSacrA and SD277 Dsll0180 pSacrA to Cm were equivalent to the tolerance of each 
strain’s respective parent strain, either SD100 or SD277, to Cm. The tolerances of SD100 
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Dslr2131 pacrB, SD277 Dslr2131 pacrB, SD100 Dsll0180 pSacrA and SD277 Dsll0180 
pSacrA to R6G, Ery, and Amp were not restored to equivalent levels as observed in 
SD100 or SD277. SD277 Dslr2131 pacrB had a significantly greater extracellular FFA 
concentration when compared to SD277 and SD277 Dslr2131. The intracellular FFA 
concentrations of SD277 Dslr2131 pacrB and SD277 Dslr2131 remain higher than 
SD277 but statistically equivalent to each other. This piece of data leads me to the 
conclusion that Slr2131 is a multidrug efflux pump that can be complemented with E. 
coli acrB. AcrB can function in Synechocystis sp. PCC 6803 to move FFA out of the cell 
to increase the extracellular FFA concentrations of SD277 Dslr2131 pacrB relative to 
SD277. This finding should lead to future studies regarding the transport of industrially 
relevant chemicals in cyanobacterial strains genetically modified to produce such 
chemicals at greater rates than the wild-type strain. 
 With the use of SD277, genetically modified to make a high concentration of FFA, 
and SD100 I was able to demonstrate some of the roles of Sll0180 and Slr2131. These 
roles included the ability to secrete Amp, Cm, Ery, and FFAs. In addition, wild-type E. 
coli acrB allele can be added to SD277 Dslr2131 to restore the extracellular FFA 
concentration that was observed in SD277.  
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CHAPTER 6 
EVALUATION AND FURTHERANCE OF RESEARCH PROGRESS 
6.1 Research progress and future goals 
 I spent a great deal of time piecing together this research project, identifying the E. 
coli AcrAB-TolC system for its abilities to secrete FFA and other related hydrocarbons 
including hexane. I then combed the SD100 genome for homologous sequences and was 
pleased to find slr1270 and slr2131 relatively quickly that are homologous to E. coli tolC 
and E. coli acrB, respectively. The homologous element to E. coli acrA took far more 
time to piece together. There was (and still is) limited research identifying MFPs in 
SD100, but there are a few proteomic studies and nucleotide sequence comparisons 
investigating two genes conferring putative MFPs SD100 sll1053 and sll0180. I choose to 
investigate the role of SD100 sll0180 after comparing the nucleotide sequences of sll1053 
and sll0180 to E. coli acrA. In addition, numerous researchers were able to show that the 
protein encoded by sll0180 existed the membrane of SD100 (20, 59, 99, 100). The data 
from Chapter 3 helps elucidate that Sll0180 and Slr2131 are both required for FFA 
secretion in SD277, a high FFA producing strain created by genetically modifying 
SD100. The four mutant strains nearly universally had a decrease of tolerance to four 
chemicals used as treatments. Sll0180 is likely an MFP associated with a multidrug efflux 
pump, and Slr2131 is likely a multidrug efflux pump. 
 In Chapter 4, I added each of the three E. coli genes that encoded the AcrAB-TolC 
efflux to expression vectors, pKan and pSpec. Both the DNA and mRNA of each of the 
E. coli genes was identified in both SD100 and SD277. The research in this section did 
not provide data illustrating the increase in extracellular FFA concentrations when any of 
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the E. coli genes were added to SD277. Unfortunately, the addition of the plasmids to 
SD277 decreased extracellular FFA concentrations in some cases, but the addition of a 
combination of wild-type E. coli acrA and wild-type E. coli tolC or wild-type E. coli 
acrA and wild-type E. coli acrB to SD277 created strains with higher extracellular FFA 
concentrations relative to SD277 pSpec pKan. So, while I still do not understand why the 
addition of plasmids would decrease extracellular FFA concentrations, I am interested in 
the facts that intracellular FFA concentrations do not decrease and growth rates are not 
changed by the addition of the plasmids. As discussed, the LexA homolog in SD100 (and 
SD277) may have a role in modulating FFA synthesis with respect to the addition of 
exogenous plasmids.  
 My final task was to complement the sll0180 and slr2131 mutations made in 
Chapter 3. The four complemented strains had their tolerance to Cm restored to 
concentrations equivalent to their respective parent strains. The SD277 Dslr2131 pacrB 
strain achieved the greatest total extracellular FFA concentration, significantly greater 
than the extracellular FFA concentration observed in SD277. 
 To continue this research, I would immediately begin placing each of these wild-
type E. coli genes at neutral sites in the Synechocystis sp. PCC 6803 chromosome, which 
have been described previously (187). One example of a neutral site in an intergenic 
region identified between slr2060 and sll1956, in which an exogenous gene could replace 
this site with likely no phenotypic differences observed. I would also remove the lexA 
homolog, sll1626, from SD277 and SD100 to investigate the role of the protein encoded 
by this gene on both FFA transport across the membrane and tolerance to toxic  
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chemicals. In particular, I would want to see if SD277 Dsll1626 decreased extracellular 
FFA concentrations when exogenous plasmids were added to the cells. 
 Additionally, both slr2131 and sll0180 should be ligated into pSpec. Then these 
two newly created plasmids should be transformed into their respective SD100 and 
SD277 deletion strains to see if the loss of function observed in Chapter 3, with respect to 
the tolerance to antibiotics and FFA efflux, can be reversed. This would provide 
additional insight into how Slr2131 and Sll0180 function with respect to efflux. A 
reversal of the loss of function would provide more evidence for the function of Slr2131 
and Sll0180 established by my research. Furthermore, I could also use an inhibitor to 
hydrogen/proton antiporter efflux, such as MBX2319, which has been shown to inhibit 
that activity of the AcrAB efflux system in E. coli (188). If the extracellular 
concentrations of FFA in SD277 is decreased significantly, this would further indicate 
that Slr2131 and Sll0180 are responsible for a significant portion of FFA efflux, as 
opposed to passive transport. Passive transport would be demonstrated if the addition of 
MBX2319 did not significantly decrease the SD277 extracellular concentration of FFA. 
 
6.2 Applications to future cyanobacterial chemical production 
 I wanted to increase the secretion of FFAs from continually growing cyanobacteria 
to foster an efficient FFA production process, in which the FFA extraction step is 
removed from the conventional processing of bacteria for FFAs. After reading a paper 
published by two of my committee members, Dr. Nielsen and Dr. Rittmann, the idea 
flourished. They, along with numerous co-authors, compare the effectiveness of various 
ways to get laurate out of the culture media without destroying the cells or requiring the 
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use of an energy intensive centrifugation to pellet the cells to allow removal of the 
supernatant (189). My initial idea was to filter or centrifuge for separation of the cells 
from the growth media, but this group of engineers presented a much more practical idea. 
This system of using FFA absorbents has the ability to gradually accumulate secreted 
FFA that my strains are able to produce.  
 slr2131 possesses similar genetic characteristics to that of E. coli acrB. The 
encoded protein of slr2131, Slr2131, share many functions to E. coli AcrB as well. 
Slr2131 extrudes antibiotics and FFA, both consistent with the function of AcrB. The 
same comparisons can be said of sll0180 and its encoded Sll0180 protein relative to E. 
coli acrA and its encoded AcrA protein. This research also provides evidence that both 
Sll0180 and Slr2131 bear some responsibility in tolerance to antibiotics and secretion of 
FFA. The removal of these proteins may have other effects in other genetically modified 
strains of SD100 including those that are engineered to produce significantly greater 
concentration of ethanol; since ethanol must be secreted to prevent cell death (43).  
 I was not anticipating the deleterious phenotypes observed in strains with the 
addition of pKan and pSpec. SD100 carries 7 plasmids itself of varying sizes, from 2.3kb 
to 120kb (190–194). Previous research uses of expression vectors to encode exogenous 
genes to increase biofuel production. Researchers encoded genes to promote the 
production of isoprene in Synechocystis sp. PCC 6803 (35). Isoprene production 
increased as a result of the genetic modifications, but the researchers did not note an 
altered isoprene production due to the addition of control plasmids lacking exogenous 
genes. 
 But many of the problems observed in this research can be readily addressed in 
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future research on biofuel production, but we have to have a consistent need for these 
alternative fuels. Without the need, there will not be the funding to support the research.  
 
6.3 Biofuels in a broader context 
Initially, research investigating cyanobacteria to produce biofuels seems 
counterintuitive. Using E. coli, one can produce far greater concentrations of FFAs than 
any photosynthetic bacteria can produce. However, E. coli while requiring a feedstock of 
sugars, E. coli grow fast, can synthesize nearly every exogenous gene using an expression 
vector or engineered into its chromosome, and the ability to produce, but not secrete 
FFAs in a continuously growing culture. E. coli can produce 400-times the concentration 
of FFAs compared to SD277 or the newly created SD277 Dslr2131 pacrB strains, but the 
Enterobacteriaceae will never be able to solve the far greater problem of getting CO2 out 
of the atmosphere. While using cyanobacterial based biofuels may just get the carbon 
sequestered temporarily, more research into producing fuels from renewable sources that 
include bacteria may lead to further discoveries that prove to be invaluable to prevent the 
Atlantic Ocean from creeping the 8 feet up to the door of Tampa’s newest condominium 
complex (195). Much of the biofuel research now focuses on identifying these optimal 
feedstocks like sawgrass or corn (196), but I argue that some of this time and energy be 
spent optimizing biofuels in photosynthetic organisms. I know that the green bacteria 
grow more slowly, are more difficult to genetically manipulate, and require more love 
and attention to grow at peak rates, but they have to possibility of helping to counteract 
the effects of the burning of fossil fuels. 
 I want to create biofuels from photosynthetic organisms using atmospheric carbon 
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dioxide as the source of the backbone of these hydrocarbons, sequestering it away from 
the accumulation of greenhouse gases even if it is only temporary. The most substantial 
problem is that gas prices have remained low for a decade. In 2006, gas prices were 
above $4 a gallon around the country for months and people did not ever see that price 
decreasing. People dumped their pickups and SUVs in favor of 4-cylinder family sedans, 
taking advantage of the Cash for Clunkers program designed to boost the American 
economy; the economic boost never came to fruition (197). As gas prices dropped, 
people hopped right back to the trucks they love. Hydraulic fracturing of oil shales has 
contributed to decreased gas prices as the United States is now the largest producer of 
natural gas (https://www.eia.gov/dnav/ng/hist/n9070us2M.htm). With mounting concerns 
over the resultant wastewater pollution and earthquakes that the pressurized liquids cause, 
hydraulic fracturing is filled with unsustainable protocols (198). Cyanobacterial fuels 
including ethanol and diesel may be a future part of the solution to present environmental 
issues with fracturing and rising greenhouse gas emissions, but there exists a current 
market for various photosynthetic organisms as dietary supplements, food additives, 
salads, and animal feeds. 
 The cyanobacterium, Arthrospira platensis, known for its vitamin B12 content and 
high protein percentage relative to total cell dry weight (199), is added under the name 
Spirulina to many green smoothies. The cyanobacteria are always the last ingredient, 
which usually means that it is present in the smallest quantity. As any person that has 
been around cyanobacteria long enough has noticed the potent odor (200) from dense, 
established cultures often described as “fishy,” which may be one of the reasons for the 
small quantity used in each smoothie. The popularity of protein powders, shakes, 
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smoothies, and other supplements is a multi-billion-dollar market, presenting large 
market for cyanobacterial protein but they do come with consumption risks (201). Other 
companies have begun marketing lipids produced in these photosynthetic organisms as 
dietary supplements including omega-3 fatty acids because of their established health 
benefits (202).  
 I think the world is heading towards electrified, self-driving cars that will initially 
be powered by batteries but will eventually be replaced by a wireless charging system on 
the road. The electricity will be derived predominantly from solar and wind energy and 
stored in massive batteries on-site or within the grid. The future of biofuels may be 
limited to commercial airline travel, which, for the time being, has no feasible plans to 
electrify. Maybe one day we will drive around our classic cars from today on biofuels, 
but until then the most responsible venture is to facilitate any reduction of greenhouse 
gases out of the atmosphere and into a sink. I hope it includes photosynthetic organisms 
and that this research provides some new insight into the efflux mechanisms that may 
help make this possible.  
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